US20220072323A1 - Medical device configured to test for user responsiveness - Google Patents
Medical device configured to test for user responsiveness Download PDFInfo
- Publication number
- US20220072323A1 US20220072323A1 US17/455,235 US202117455235A US2022072323A1 US 20220072323 A1 US20220072323 A1 US 20220072323A1 US 202117455235 A US202117455235 A US 202117455235A US 2022072323 A1 US2022072323 A1 US 2022072323A1
- Authority
- US
- United States
- Prior art keywords
- patient
- controller
- response
- wearable defibrillator
- response mechanism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000004043 responsiveness Effects 0.000 title description 9
- 238000012360 testing method Methods 0.000 title description 9
- 230000004044 response Effects 0.000 claims abstract description 165
- 230000007246 mechanism Effects 0.000 claims abstract description 76
- 239000003550 marker Substances 0.000 claims description 33
- 230000035939 shock Effects 0.000 claims 4
- 230000001225 therapeutic effect Effects 0.000 claims 4
- 238000000034 method Methods 0.000 description 18
- 238000012545 processing Methods 0.000 description 12
- 206010003119 arrhythmia Diseases 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 238000002513 implantation Methods 0.000 description 5
- 230000000007 visual effect Effects 0.000 description 5
- 230000004913 activation Effects 0.000 description 3
- 230000000981 bystander Effects 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 206010011086 Coronary artery occlusion Diseases 0.000 description 2
- 206010049447 Tachyarrhythmia Diseases 0.000 description 2
- 208000001871 Tachycardia Diseases 0.000 description 2
- 208000003443 Unconsciousness Diseases 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 101100188555 Arabidopsis thaliana OCT6 gene Proteins 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000013479 data entry Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 238000002496 oximetry Methods 0.000 description 1
- 230000010399 physical interaction Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3993—User interfaces for automatic external defibrillators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/046—Specially adapted for shock therapy, e.g. defibrillation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
- A61N1/0484—Garment electrodes worn by the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3904—External heart defibrillators [EHD]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3925—Monitoring; Protecting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3987—Heart defibrillators characterised by the timing or triggering of the shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37211—Means for communicating with stimulators
- A61N1/37217—Means for communicating with stimulators characterised by the communication link, e.g. acoustic or tactile
Definitions
- This invention relates to devices and methods used to test the responsiveness of a person using or wearing a medical device, such as, for example, a wearable defibrillator.
- Wearable defibrillators are often used to help people with heart conditions that make them susceptible to life threatening cardiac arrhythmias. Such wearable defibrillators are typically configured to quickly treat a life threatening cardiac arrhythmia that is detected while a patient is wearing the device.
- U.S. Pat. Nos. 4,928,690, 5,078,134, 5,741,306, 5,944,669, 6,065,154, 6,097,987, 6,253,099, 6,280,461 and 6,681,003 disclose wearable defibrillators.
- the entirety of U.S. Pat. Nos. 4,928,690, 5,078,134, 5,741,306, 5,944,669, 6,065,154, 6,097,987, 6,253,099, 6,280,461 and 6,681,003, are hereby incorporated herein by reference.
- Wearable defibrillators are typically used to help patients that either cannot risk an implantation of a defibrillator or are awaiting such an implantation. Occasionally, a patient wearing a wearable defibrillator may appear to be experiencing a life threatening cardiac arrhythmia, but is not having such an event. In such circumstances, the wearable defibrillator is often configured to generate an audible alarm that is designed to stop if a patient provides a required response, such as, for example, pressing one or more response buttons. If a patient fails to press such buttons or otherwise provide a required response, the device may be configured to determine that the patient is unconscious and is undergoing a condition requiring treatment.
- a passerby or bystander may interfere with the device by intentionally pressing the response buttons or otherwise providing a response to the wearable device causing the device to withhold treatment to a patient.
- Such interference can have tragic consequences because it may delay treatment a patient may need.
- such interference may harm the patient by improperly delaying treatment and, in some cases, may result in patient death.
- the present invention is directed towards overcoming one or more of the above-mentioned problems.
- a wearable defibrillator includes one or more controllers, one or more treatment electrodes, one or more sensors and one or more response mechanisms.
- the one or more controllers are connected to at least one of the one or more sensors and one or more treatment electrodes.
- the one or more response mechanisms are connected to the one or more controllers and are actuatable by a patient wearing the wearable defibrillator.
- the one or more controllers are configured to receive input from the one or more response mechanisms and determine whether the patient wearing the wearable defibrillator actuated that one or more response mechanisms based at least in part on the input.
- the one or more response mechanisms can include one or more detectors, one or more transducers, or any combination thereof.
- the one or more response mechanisms may include at least one button connected to one or more detectors, one or more transducers or any combination thereof.
- the one or more transducers are biometric transducers and the one or more detectors are biometric sensors.
- the one or more transducers of the one or more response mechanisms can be configured to send a marker signal and the one or more detectors of the one or more response mechanisms can be configured to receive the marker signal and transmit at least a portion of the received marker signal to the one or more controllers.
- the wearable defibrillator fray also include one or more falloff signal generators connected to at least one of the one or more controllers, one or more sensors and one more treatment electrodes.
- the one or more falloff signal generators can be configured to transmit a falloff signal through at least a portion of the patient's body.
- the one or more response mechanisms include one or more detectors that are configured to receive the falloff signal when the patient actuates the response mechanism.
- the one or more response mechanisms may include at least one detector configured to detect the capacitance of a person actuating the response mechanism and the one or more controllers are configured to determine a capacitance value from the input.
- the one or more controllers are configured to compare the detected capacitance value to a range of patient capacitance values to determine if the patient actuated the response mechanism.
- the one or more sensors can be configured to receive an ECG signal from the patient and the one or more response mechanisms can include at least one detector configured to receive an ECG signal of a person actuating the one or more response mechanisms.
- the one or more controllers are configured to compare the ECG signal received by the one or more sensors and the ECG signal received by the one or more detectors to determine whether the patient actuated the one or more response mechanisms based at least in part on the input.
- the one or more controllers may be configured to compare the ECG signals received by the one or more sensors and one or more detectors by utilizing at least one of morphology comparisons, rate comparisons and R-wave synchronizations.
- the wearable defibrillator can also include at least one accessory item connected to the one or more controllers.
- the one or more accessory items include at least one ring, at least one badge, at least one bracelet or any combination thereof.
- the one or more accessory items include at least one identification marker configured to transmit an identification signal.
- One or more response mechanisms may also include at least one detector configured to receive the identification signal.
- a method of testing patient responsiveness of a patient wearing a medical device includes sensing via sensors on the medical device a condition of the patient requiring treatment, providing a prompt emitted from the medical device that is directed to the patient to elicit a response from the patient upon sensing the condition requiring treatment, and determining if the patient has provided the response if a response is provided.
- One embodiment of the method may further include sensing for a signal and, if a response is provided, verifying whether the provided response includes the signal. Preferably, verifying that the response includes the signal occurs during the step of determining whether the patient has provided the response.
- Another embodiment of the method can also include measuring capacitance and, if a response is provided, comparing the measured capacitance to a stored patient capacitance to determine whether the patient provided the response. Yet another embodiment of the method may also include detecting an accessory item worn by the patient to determine if the patient has provided the response during the step of determining if the patient has provided the response if a response is provided.
- Some embodiments of the method may additionally include sensing ECG signals of the patient and comparing the ECG signals of the patient with ECG signals provided with the response, if a response is provided and is a step used to determine whether the patient provided the response.
- inventions of the method can also include requiring entry of at least one of a code and a password.
- requiring entry of a code, password or any combination thereof occurs during the step of determining whether the patient provided the response.
- FIG. 1 is a schematic view of a first present preferred embodiment of a wearable defibrillator, which utilizes a marker signal to test for user responsiveness.
- FIG. 2 is a block diagram of a present preferred embodiment of a controller that includes a display and a speaker.
- FIG. 3 a schematic view of a second present preferred embodiment of a wearable defibrillator, which utilizes a falloff signal to test for user responsiveness.
- FIG. 4 is a block diagram illustrating a first present preferred method of providing treatment to a patient wearing the second present preferred embodiment of a wearable defibrillator.
- FIG. 5 is a schematic view of a third present preferred embodiment of a wearable defibrillator, which utilizes ECG signals to test for user responsiveness.
- FIG. 6 is a block diagram illustrating a second present preferred method of providing treatment to a patient wearing the third present preferred embodiment of a wearable defibrillator.
- FIG. 7 is a block diagram illustrating the second present preferred method of providing treatment to a patient wearing the third present preferred embodiment of a wearable defibrillator when a non-patient provides a response to a prompt emitted from the third present preferred embodiment of a wearable defibrillator.
- FIG. 8 is a schematic view of a fourth present preferred embodiment of a wearable defibrillator, which utilizes a touch sensor to test for user responsiveness.
- FIG. 9 is a block diagram illustrating a third present preferred method of providing treatment to a patient wearing the fourth present preferred embodiment of a wearable defibrillator.
- FIG. 10 is a schematic view of a fifth present preferred embodiment off wearable defibrillator, which utilizes one or more accessory items that transmit an identification marker to a monitoring device to verify user responsiveness.
- FIG. 1 A patient 1 wearing a wearable defibrillator 31 that is configured to be worn as a vest is illustrated in FIG. 1 .
- the wearable defibrillator 31 includes sensing electrodes 4 connected to a controller 2 by wiring 3 . Treatment electrodes 5 are also connected to the controller 2 .
- the controller 2 includes at least one response button 6 .
- the response button 6 is configured to transmit a unique marker signal 11 into the body of a person touching the button 6 .
- the marker signal 11 is transmitted throughout the entire body of the person touching the button 6 .
- the marker signal 11 may be analog or digital and should have electrical characteristics that are safe for the person touching the response button 6 , which preferably will be the patient 1 .
- the marker signal Ills of an electronically generated low amplitude signal that will not harm the patient 1 .
- the marker signal 11 may include encoded information unique to either the patient 1 or the wearable defibrillator 31 worn by the patient 1 .
- the sensing electrodes 4 are configured to detect the marker signal 11 along with the cardiac ECG 12 or other biometric signals of the patient 1 ,
- the controller 2 is configured to receive the marker signal 11 and input from one or more of the sensors 4 that are configured to receive the marker signal 11 and decode the marker signal 11 and input from the one or more sensors 4 .
- the sensors 4 may also be configured to sense ECG signals or other biometric signals.
- the controller 2 is configured to verify that the marker signal 11 is being sent into the patient 1 . It should be appreciated that the verification of the marker signal 11 can permit the controller 2 to ensure that any person that may actuate the response button 6 cannot prevent the rendering of treatment by the defibrillator unless that person is the patient 1 .
- FIG. 2 A present preferred embodiment of a circuit that may be used in the controller 2 is illustrated in FIG. 2 .
- the present preferred embodiment of the circuit can be used in the wearable defibrillator embodiment shown in FIG. 1 .
- the circuit includes a marker signal generator 16 that is connected to the response button 6 .
- a microcontroller 7 is connected to the marker signal generator 16 , a signal processing circuit 8 , a defibrillator processing circuit 9 and a patient notification circuit 10 .
- the response button 6 may include a biometric transducer 17 or other transducer configured to emit the marker signal 11 generated by the marker signal generator 16 into the body of a person touching the button 6 .
- the signal processing circuit 8 is configured to receive the marker signal 11 transmitted by the transducer 17 into the body of the patient 1 .
- the microcontroller 7 is configured so that treatment from the treatment electrodes 5 is provided to the patient 1 .
- the microcontroller 7 is configured to process a treatment algorithm or program either stored in the microcontroller 7 , operatively connected to the microcontroller 7 or programmed into the defibrillator processing circuit 9 .
- the treatment algorithm may require the controller 2 to verify that the sensed condition of the patient 1 indicates treatment is needed, that the response button 6 has been activated, and that the marker signal 11 has been received to verify that the person activating the response button 6 is the patient 1 .
- the defibrillator processing circuit 9 is configured to cause the treatment electrodes 5 to activate to provide treatment to the patient 1 .
- the defibrillator processing circuit 9 or microcontroller 7 is configured so that the treatment electrodes 5 do not provide treatment to the patient 1 since the patient 1 must be conscious in order to actuate the response button 6 .
- the controller 2 may be configured to send additional instructions that are relayed to the patient or bystander as audible output, visual output, or both. For example, if a non-patient improperly presses the response button 6 , the controller 2 may be configured to ensure instructions are directed to the non-patient that informs the non-patient that treatment will soon be offered to the patient or that the non-patient should not press the response button 6 and that the non-patient should move away from and not touch the patient 1 . Of course, the controller 2 may also be configured to cause other instructions or prompts to be transmitted to a non-patient, patient or both.
- the microcontroller 7 may also be configured to provide audible instructions, visual instructions, or a combination of both audible and visual instructions to a patient 1 or others located near the patient 1 .
- the microcontroller 7 can be connected to an audio speaker or display located on or in a housing of the controller 2 or located in another device that is worn by the patient 1 or connected to the controller 2 .
- the controller 2 can be configured so that instructions or prompts are directed toward the patient 1 .
- visual instructions may be displayed on the display, such as for example, an LCD display, or other display connected to the controller 2 .
- the instructions may also be audibly provided to the patient 1 as output transmitted by the speaker or other audible output device.
- alternate embodiments may include a response button 6 that does not have any mechanical action or functionality.
- one alternate embodiment may include an actuator affixed to the housing of the controller or an actuator that is integral with the housing of the controller 2 .
- a portion of the controller housing may include indicia identifying the location of a biometric transducer 17 that is integral with that portion of the controller housing so a patient will know where to place a finger or other portion of the patient's body to respond to alarms or other prompts used to ask the patient to verify that the patient is awake and not in need of treatment.
- a wearable defibrillator can also be configured to utilize a falloff signal 14 to determine that the patient 1 is responding to prompts or instructions and verify that the patient is conscious and not in need of treatment.
- FIG. 3 shows a wearable defibrillator 41 that utilizes a falloff signal 14 .
- FIG. 4 A block diagram illustrating the processing of the second present preferred embodiment of the defibrillator 41 is shown in FIG. 4 .
- One or more therapy electrodes 5 or treatment electrodes, are configured to emit a unique falloff marker signal 14 into the body of the patient 1 .
- One or more of the sensors 4 of the defibrillator 41 are configured to sense the falloff signal 14 .
- the falloff signal 14 has electrical characteristics that permit the one or more sensors 4 to also sense other biometric signals, such as, for example, ECG signals and other signals.
- the controller 2 is configured to detect the existence of the falloff signal 14 .
- the controller 2 may also be configured to detect if a sensor 4 has fallen off the body. For example, the controller 2 may be configured to determine that a sensor 4 has become disconnected from the body of the patient 1 if the falloff marker signal 14 is not detected by one of the sensors 4 , but is detected by other sensors 4 . If the controller 2 determines such a condition exists, the controller may be configured to provide one or more prompts or instructions to the patient 1 to reattach the dislodged sensor 4 . Such a prompt or instruction may be provided on a display connected to the controller 2 or a speaker connected to the controller 2 .
- the controller 2 includes a microcontroller 7 that is connected to a falloff signal generator 17 , the sensors 4 , a patient notification circuit 10 , defibrillator circuits 9 and a signal processing circuit 8 .
- the signal processing circuit 8 , patient notification circuit 10 and microcontroller 7 may be located within the housing of the controller 2 .
- the falloff signal generator 17 is connected to the sensors 4 . In other embodiments, the fall off signal generator 17 may be connected to a separate device worn by the patient 1 , such as, for example, the treatment electrodes 5 .
- the response button 6 includes a biometric detector 18 or other biometric sensor that is configured to receive the falloff signal 14 from the body of the person contacting the response button.
- the signal processing circuit 8 is configured to determine whether the falloff signal 14 has been received from the biometric sensor 18 .
- the controller 2 is configured to determine whether the response button 6 has been activated and, if so, whether the falloff signal 14 was received from the biometric sensor 18 . If both the falloff signal 14 was received and the response button 6 was actuated, the controller 2 is configured to determine that the patient 1 actuated the response button 6 . It should be appreciated that such a determination can be used to verify that a patient 1 is responding to prompts or instructions displayed or played by notification devices such as, for example, a monitor or speaker, connected to the controller 2 .
- FIGS. 5, 6 and 7 A third embodiment of a wearable defibrillator 51 is illustrated in FIGS. 5, 6 and 7 .
- the response button 6 of the wearable defibrillator 51 includes an ECG detector 19 that is configured to sense the ECG signal 12 of the patient 1 wearing the defibrillator.
- the ECG detector 19 may be attached to response button 6 such that at least a portion of the detector 19 extends out of the outer surface of the response button 6 , may be attached on the outer surface of the response button 6 , or may be otherwise connected to the response button 6 .
- the ECG detector 19 is an ECG electrode that is similar in design to ECG sensors 4 that are attached to the defibrillator 51 .
- the controller 2 of the defibrillator 51 may be configured to confirm that the patient 1 is actuating the response button 6 by correlating any ECG signal 20 received by the ECG detector 19 with the ECG signals 20 , 21 received by the ECG sensors 4 worn by the patient 1 .
- the controller 2 can be configured to compare the ECG signals received by the ECG detector 19 to the ECG signals received by the ECG sensors 4 worn by the patient 1 in various ways.
- the controller 2 may be configured to utilize morphology comparisons, rate comparison, R-wave synchronization or any combination thereof to compare the ECG signals 20 , 21 and determine whether the ECG signals 20 , 21 received by ECG detector 19 to verify that the person actuating the response button 6 is the patient 1 .
- the ECG signal received by the ECG detector 19 will be an ECG signal that is not a match to the patient ECG signal being received by the sensors 4 . It should also be appreciated that if a person that is not the patient 1 does not have a common ground reference to the circuitry of the defibrillator 51 , a corrupt signal or no signal at all may be received by the controller 2 .
- the signal processing circuit 8 or microcontroller 7 can be configured to recognize that the signal received from the ECG detector 19 does not match the signals received from the sensors 4 .
- the controller 2 may be configured to disregard any actuation of the response button 6 that the controller 2 determines was made by a person that is not the patient 1 .
- the controller 2 may also be configured to provide prompts or instructions to a non-patient that has actuated a response button to inform the non-patient that he or she should not respond to the prompts, request additional input to verify the person actuating the response button is not the patient 1 , or inform the non-patient that treatment is about to be provided to the patient 1 and, consequently, that he or she should move away from the patient 1 .
- FIGS. 8 and 9 depict a wearable defibrillator 61 configured to verify a patient 1 is actuating a response button 6 or actuating some other response mechanism by detecting a capacitance value of the person or object actuating the response button.
- the capacitance value can be used to verify whether the patient 1 or some other person has actuated the response mechanism.
- the measured capacitance value can be compared with a value or range of values related to the patient that are stored in the controller to verify that the patient actuated the response mechanism.
- the stored capacitance value or range of capacitance values may be stored in the controller 2 during the start-up procedure for the defibrillator or may be stored and saved by the controller 2 during an initial use of the defibrillator by the patient 1 and reused by the controller 2 until a new value or range of values is saved to the controller 2 to replace the old value or range of values.
- the controller 2 of wearable defibrillator 61 includes a response button 6 that has a capacitive detector 22 or other capacitive sensor.
- the capacitive detector 22 is a capacitive type electrode.
- the capacitive detector 22 is connected to a touch sensor 15 or other circuitry that is configured to detect variations in capacitance 23 due to patient specific physical interaction with the response button 6 and capacitive detector 22 .
- the controller 2 can be configured to determine when the response button 6 has been actuated by the patient 1 by comparing the capacitance value sensed by the capacitance detector 22 with a capacitance value or range of capacitance values stored in the controller 2 or in memory connected to the controller 2 .
- the controller 2 is configured to determine that the patient 1 did not actuate the response button 6 .
- the controller 2 may be configured to disregard actuation of the response button 6 if it is determined that the patient 1 did not actuate the response button 6 and may also be configured to provide one or more prompts or instructions to the non-patient that may have actuated the response button 6 .
- Accessory items may also be used to verify that a patient is providing input to a wearable defibrillator.
- the embodiment of the wearable defibrillator 71 shown in FIG. 10 includes one or more accessory items that transmit an identification marker 26 to the controller 2 of the defibrillator.
- the accessory items may be a finger ring 24 , bracelet 25 , necklace, lanyard, earring, badge, name tag, any other accessory that may be worn by a user or any combination thereof.
- the controller 2 can include one or more receivers or other detectors that are configured to receive the identification marker transmitted by the one or more accessory items.
- the controller 2 may also be configured to determine when an accessory item is close to the housing of the controller 2 or a monitor or other display connected to the controller 2 .
- a magnetic proximity detector 27 or other proximity sensor configured to detect one or more of the accessory items may be provided on or connected to the controller 2 .
- the controller 2 can be configured to utilize the presence of the accessory item to verify that the patient is actuating a response mechanism such as for example response button 6 .
- the controller 2 may also be configured to verify that all response mechanism actuations are made by a patient during a treatment sequence run or controlled by the controller 2 .
- the controller 2 can be configured to ignore the actuation of a response mechanism or transmit additional patient prompts, alarms or instructions through a display or speaker connected to the controller 2 if a correlating identification accessory is not sensed or is not sensed to be within a certain distance from the controller 2 or receiver.
- the location of the response mechanism such as, for example, one or more response buttons 6 may be sized and configured to avoid accidental activation or a response by someone other than the patient.
- the response mechanism may include one or more buttons that are located on the housing of the controller 2 in a hidden or obscured location.
- a hidden location may be a recessed portion of the controller housing.
- Another example of such a hidden location may be locating one or more response buttons 6 under a latch or cover that is moveably connected to the housing of the controller 2 or a display connected to the controller 2 .
- the response mechanism may be a device that has one or more actuators that are wirelessly connected to the controller 2 . Such a device may be within the pocket of an article of clothing worn by a patient or positioned in another location a typical passerby would be unlikely to see or find.
- response buttons 6 may be connected to the controller 2 .
- two or ore response buttons are used such that simultaneous activation of the two or more buttons is required to actuate the response mechanism. Such a configuration can reduce false positive detection.
- actuation of a response mechanism may also include actuating one or more response buttons in a particular sequence.
- the controller 2 or response mechanism may be configured so that actuation of a response mechanism occurs when a patient presses different buttons in a particular sequence or moves one or more response switches or other buttons to different positions.
- the response mechanism could be configured so that movement of the switch from a first position to a second position and then back to the first position within a certain time interval was necessary to actuate the response mechanism.
- one or more additional sensors may be used to avoid accidental activation or a response by a non-patient.
- additional sensors may include a biometric sensor such as for example a fingerprint, voice, or face recognition sensor.
- the controller 2 can be configured to require input from the additional sensor that correlates with patient data stored in the controller 2 or stored in memory connected to the controller 2 to verify that a patient is actuating a response mechanism or otherwise providing input to the controller 2 .
- the controller 2 can also be configured to use other verification methods to provide additional input that confirms a patient is providing input to the controller 2 .
- a feedback loop that includes a current path to the controller 2 or a current path to a display device connected to the controller 2 may also be used to verify that a patient is providing input to the controller 2 .
- One or more additional sensors may also include a motion, position or oximetry detector located on another area of the patient's body and connected to the controller 2 .
- the controller 2 could be configured to obtain input from such sensors to aid the controller 2 in determining the condition of the patient 1 .
- Embodiments of a wearable defibrillator may also include a controller 2 configured to receive a code or password from a patient 1 .
- the password or code may be provided to the controller 2 by use of one or more buttons, a key pad, or other data entry device connected to or located on the controller 2 .
- the controller 2 could be configured to require entry of the password or code at any time during the sequence of alarms or other prompts or instructions to prevent someone other than the patient from inadvertently giving a response when the patient 1 is unconscious.
- a code could also include pressing one or more response buttons, one or more response switches, or other response actuators in a certain sequence.
- the controller 2 can also be configured to verify that the response mechanism is working properly to avoid or mitigate errors resulting from broken or damaged response mechanisms.
- the controller 2 can be configured to routinely test the response mechanism for proper functionality or monitor the response mechanism to predict a failure of the response mechanism. For instance, the controller 2 can be configured to conduct a response test each time the defibrillator is turned on. In the event the controller 2 does not receive input from the response mechanism or otherwise recognize any actuation of the response mechanism during a test of the response mechanism, the controller 2 may be configured to provide one or more audible or visual prompts to the patient 1 that informs the patient 1 the response mechanism is broken or needs to be repaired.
- the controller 2 may also be configured to use an alternate responsiveness test method if one is available or inform the patient 1 that to prevent treatment, it would be necessary to remove the power source from the controller 2 .
- the controller 2 may also be configured so that it deactivates the defibrillator after it determines that the response mechanism is not functioning properly.
- the controller 2 may be configured to process a prediction algorithm configured to predict future failure of the response mechanism.
- the controller 2 can be configured to alert the patient 1 , disable the defibrillator, or both.
- embodiments of the wearable defibrillator can be sized and configured to be worn as a harness, belt, vest, or other wearable device.
- a response mechanism can include one or more response buttons, response switches, other response actuators or any combination thereof.
- the controller 2 of the wearable defibrillator may be connected to different components of the wearable defibrillator by one or more direct or indirect wireless connections, direct or indirect wired connections, or any combination thereof.
- the treatment electrodes may include various types of treatment electrodes known to those skilled in the art, such as, for example, pulse electrodes disclosed in U.S. Pat. No. 5,078,134.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Radiology & Medical Imaging (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Human Computer Interaction (AREA)
- Electrotherapy Devices (AREA)
Abstract
A medical device is disclosed that includes one or more treatment electrodes, one or more sensors, and one or more controllers connected to the one or more treatment electrodes and one or more sensors. The medical device also includes one or more response mechanisms connected to the one or more controllers. The one or more controllers are configured to receive input from the one or more response mechanism and are also configured to determine whether a patient wearing the medical device actuated the one or more response mechanisms based, at least in part, on the input received from the one or more response mechanisms. In some disclosed embodiments, the medical device is a wearable defibrillator.
Description
- This application is a continuation of U.S. patent application Ser. No. 16/546,655 (filed 21 Aug. 2019), which is a continuation of U.S. patent application Ser. No. 15/205,542 (filed 8 Jul. 2016, now U.S. Pat. No. 10,434,321), which is a continuation of U.S. patent application Ser. No. 14/876,322 (filed 6 Oct. 2015, now U.S. Pat. No. 10,328,275), which is a continuation of U.S. patent application Ser. No. 13/612,400 (filed 12 Sep. 2012, now U.S. Pat. No. 9,370,666), which is a continuation of U.S. patent application Ser. No. 12/150,720 (filed 30 Apr. 2008, now U.S. Pat. No. 8,271,082), which claims priority to U.S. Provisional Patent Application 60/933,550 (filed 7 Jun. 2007), each of which is hereby incorporated herein by reference in its entirety.
- This invention relates to devices and methods used to test the responsiveness of a person using or wearing a medical device, such as, for example, a wearable defibrillator.
- There are many patients susceptible to heart arrhythmias who are at risk of sudden death. For example, patients experiencing a coronary artery occlusion and myocardial infarction are at substantial risk of tachyarrhythmia for several weeks following the coronary artery occlusion. Such patients are generally hospitalized but can be discharged earlier if there is a practical means to protect them from life threatening arrhythmias. One such practical means includes the implantation of an automatic defibrillator. However, patients may also be discharged prior to such an implantation if an external defibrillator, such as, for example, a wearable defibrillator, is available in case they experience a life-threatening tachyarrhythmia.
- There are also patients who are placed at an inordinate risk due to the surgery required for implanting an implantable defibrillator. For such patients, implantation would preferably be avoided so such an inordinate risk could be avoided or otherwise mitigated.
- Wearable defibrillators are often used to help people with heart conditions that make them susceptible to life threatening cardiac arrhythmias. Such wearable defibrillators are typically configured to quickly treat a life threatening cardiac arrhythmia that is detected while a patient is wearing the device. For example, U.S. Pat. Nos. 4,928,690, 5,078,134, 5,741,306, 5,944,669, 6,065,154, 6,097,987, 6,253,099, 6,280,461 and 6,681,003, disclose wearable defibrillators. The entirety of U.S. Pat. Nos. 4,928,690, 5,078,134, 5,741,306, 5,944,669, 6,065,154, 6,097,987, 6,253,099, 6,280,461 and 6,681,003, are hereby incorporated herein by reference.
- Wearable defibrillators are typically used to help patients that either cannot risk an implantation of a defibrillator or are awaiting such an implantation. Occasionally, a patient wearing a wearable defibrillator may appear to be experiencing a life threatening cardiac arrhythmia, but is not having such an event. In such circumstances, the wearable defibrillator is often configured to generate an audible alarm that is designed to stop if a patient provides a required response, such as, for example, pressing one or more response buttons. If a patient fails to press such buttons or otherwise provide a required response, the device may be configured to determine that the patient is unconscious and is undergoing a condition requiring treatment.
- Occasionally, a passerby or bystander may interfere with the device by intentionally pressing the response buttons or otherwise providing a response to the wearable device causing the device to withhold treatment to a patient. Such interference can have tragic consequences because it may delay treatment a patient may need. For example, such interference may harm the patient by improperly delaying treatment and, in some cases, may result in patient death.
- There is a need for wearable defibrillators and other medical devices to verify that a user providing a response is the patient and not a bystander by preventing anyone except the patient from responding when the patient is undergoing an event that could require treatment. Such verification preferably occurs during episodes of treatable cardiac arrhythmias.
- The present invention is directed towards overcoming one or more of the above-mentioned problems.
- A wearable defibrillator is provided that includes one or more controllers, one or more treatment electrodes, one or more sensors and one or more response mechanisms. The one or more controllers are connected to at least one of the one or more sensors and one or more treatment electrodes. The one or more response mechanisms are connected to the one or more controllers and are actuatable by a patient wearing the wearable defibrillator. The one or more controllers are configured to receive input from the one or more response mechanisms and determine whether the patient wearing the wearable defibrillator actuated that one or more response mechanisms based at least in part on the input.
- In some embodiments, the one or more response mechanisms can include one or more detectors, one or more transducers, or any combination thereof. In other embodiments, the one or more response mechanisms may include at least one button connected to one or more detectors, one or more transducers or any combination thereof. Preferably, the one or more transducers are biometric transducers and the one or more detectors are biometric sensors. In one embodiment, the one or more transducers of the one or more response mechanisms can be configured to send a marker signal and the one or more detectors of the one or more response mechanisms can be configured to receive the marker signal and transmit at least a portion of the received marker signal to the one or more controllers.
- In other embodiments, the wearable defibrillator fray also include one or more falloff signal generators connected to at least one of the one or more controllers, one or more sensors and one more treatment electrodes. The one or more falloff signal generators can be configured to transmit a falloff signal through at least a portion of the patient's body. Preferably, the one or more response mechanisms include one or more detectors that are configured to receive the falloff signal when the patient actuates the response mechanism.
- In another embodiment, the one or more response mechanisms may include at least one detector configured to detect the capacitance of a person actuating the response mechanism and the one or more controllers are configured to determine a capacitance value from the input. Preferably, the one or more controllers are configured to compare the detected capacitance value to a range of patient capacitance values to determine if the patient actuated the response mechanism.
- In some embodiments, the one or more sensors can be configured to receive an ECG signal from the patient and the one or more response mechanisms can include at least one detector configured to receive an ECG signal of a person actuating the one or more response mechanisms. Preferably, the one or more controllers are configured to compare the ECG signal received by the one or more sensors and the ECG signal received by the one or more detectors to determine whether the patient actuated the one or more response mechanisms based at least in part on the input. In one embodiment, the one or more controllers may be configured to compare the ECG signals received by the one or more sensors and one or more detectors by utilizing at least one of morphology comparisons, rate comparisons and R-wave synchronizations.
- In other embodiments, the wearable defibrillator can also include at least one accessory item connected to the one or more controllers. Preferably, the one or more accessory items include at least one ring, at least one badge, at least one bracelet or any combination thereof. In one embodiment, the one or more accessory items include at least one identification marker configured to transmit an identification signal. One or more response mechanisms may also include at least one detector configured to receive the identification signal.
- A method of testing patient responsiveness of a patient wearing a medical device is also provided. The method includes sensing via sensors on the medical device a condition of the patient requiring treatment, providing a prompt emitted from the medical device that is directed to the patient to elicit a response from the patient upon sensing the condition requiring treatment, and determining if the patient has provided the response if a response is provided.
- One embodiment of the method may further include sensing for a signal and, if a response is provided, verifying whether the provided response includes the signal. Preferably, verifying that the response includes the signal occurs during the step of determining whether the patient has provided the response.
- Another embodiment of the method can also include measuring capacitance and, if a response is provided, comparing the measured capacitance to a stored patient capacitance to determine whether the patient provided the response. Yet another embodiment of the method may also include detecting an accessory item worn by the patient to determine if the patient has provided the response during the step of determining if the patient has provided the response if a response is provided.
- Some embodiments of the method may additionally include sensing ECG signals of the patient and comparing the ECG signals of the patient with ECG signals provided with the response, if a response is provided and is a step used to determine whether the patient provided the response.
- Other embodiments of the method can also include requiring entry of at least one of a code and a password. Preferably, requiring entry of a code, password or any combination thereof occurs during the step of determining whether the patient provided the response.
- Other details, objects, and advantages of the invention will become apparent as the following description of certain present preferred embodiments thereof and certain present preferred methods of practicing the same proceeds.
- Present preferred embodiments of the invention are shown in the accompanying drawings and certain present preferred methods of practicing the same are also illustrated therein,
-
FIG. 1 is a schematic view of a first present preferred embodiment of a wearable defibrillator, which utilizes a marker signal to test for user responsiveness. -
FIG. 2 is a block diagram of a present preferred embodiment of a controller that includes a display and a speaker. -
FIG. 3 a schematic view of a second present preferred embodiment of a wearable defibrillator, which utilizes a falloff signal to test for user responsiveness. -
FIG. 4 is a block diagram illustrating a first present preferred method of providing treatment to a patient wearing the second present preferred embodiment of a wearable defibrillator. -
FIG. 5 is a schematic view of a third present preferred embodiment of a wearable defibrillator, which utilizes ECG signals to test for user responsiveness. -
FIG. 6 is a block diagram illustrating a second present preferred method of providing treatment to a patient wearing the third present preferred embodiment of a wearable defibrillator. -
FIG. 7 is a block diagram illustrating the second present preferred method of providing treatment to a patient wearing the third present preferred embodiment of a wearable defibrillator when a non-patient provides a response to a prompt emitted from the third present preferred embodiment of a wearable defibrillator. -
FIG. 8 is a schematic view of a fourth present preferred embodiment of a wearable defibrillator, which utilizes a touch sensor to test for user responsiveness. -
FIG. 9 is a block diagram illustrating a third present preferred method of providing treatment to a patient wearing the fourth present preferred embodiment of a wearable defibrillator. -
FIG. 10 is a schematic view of a fifth present preferred embodiment off wearable defibrillator, which utilizes one or more accessory items that transmit an identification marker to a monitoring device to verify user responsiveness. - A
patient 1 wearing awearable defibrillator 31 that is configured to be worn as a vest is illustrated inFIG. 1 . Thewearable defibrillator 31 includessensing electrodes 4 connected to acontroller 2 bywiring 3.Treatment electrodes 5 are also connected to thecontroller 2. Thecontroller 2 includes at least oneresponse button 6. Theresponse button 6 is configured to transmit aunique marker signal 11 into the body of a person touching thebutton 6. Preferably, themarker signal 11 is transmitted throughout the entire body of the person touching thebutton 6. - The
marker signal 11 may be analog or digital and should have electrical characteristics that are safe for the person touching theresponse button 6, which preferably will be thepatient 1. Preferably, the marker signal Ills of an electronically generated low amplitude signal that will not harm thepatient 1. Themarker signal 11 may include encoded information unique to either thepatient 1 or thewearable defibrillator 31 worn by thepatient 1. - The
sensing electrodes 4 are configured to detect themarker signal 11 along with thecardiac ECG 12 or other biometric signals of thepatient 1, Thecontroller 2 is configured to receive themarker signal 11 and input from one or more of thesensors 4 that are configured to receive themarker signal 11 and decode themarker signal 11 and input from the one ormore sensors 4. Thesensors 4 may also be configured to sense ECG signals or other biometric signals. - The
controller 2 is configured to verify that themarker signal 11 is being sent into thepatient 1. It should be appreciated that the verification of themarker signal 11 can permit thecontroller 2 to ensure that any person that may actuate theresponse button 6 cannot prevent the rendering of treatment by the defibrillator unless that person is thepatient 1. - A present preferred embodiment of a circuit that may be used in the
controller 2 is illustrated inFIG. 2 . The present preferred embodiment of the circuit can be used in the wearable defibrillator embodiment shown inFIG. 1 . The circuit includes amarker signal generator 16 that is connected to theresponse button 6. Amicrocontroller 7 is connected to themarker signal generator 16, asignal processing circuit 8, adefibrillator processing circuit 9 and apatient notification circuit 10. Theresponse button 6 may include abiometric transducer 17 or other transducer configured to emit themarker signal 11 generated by themarker signal generator 16 into the body of a person touching thebutton 6. - The
signal processing circuit 8 is configured to receive themarker signal 11 transmitted by thetransducer 17 into the body of thepatient 1. In the event that themaker signal 11 is not received from the body of thepatient 1, themicrocontroller 7 is configured so that treatment from thetreatment electrodes 5 is provided to thepatient 1. In the event thesignal processing circuit 8 receives themarker signal 11 transmitted by thebiometric transducer 17, themicrocontroller 7 is configured to process a treatment algorithm or program either stored in themicrocontroller 7, operatively connected to themicrocontroller 7 or programmed into thedefibrillator processing circuit 9. - The treatment algorithm may require the
controller 2 to verify that the sensed condition of thepatient 1 indicates treatment is needed, that theresponse button 6 has been activated, and that themarker signal 11 has been received to verify that the person activating theresponse button 6 is thepatient 1. In the event apatient 1 does not activate theresponse button 6 or other actuator, thedefibrillator processing circuit 9 is configured to cause thetreatment electrodes 5 to activate to provide treatment to thepatient 1. In the event thepatient 1 actuates theresponse button 6, thedefibrillator processing circuit 9 ormicrocontroller 7 is configured so that thetreatment electrodes 5 do not provide treatment to thepatient 1 since thepatient 1 must be conscious in order to actuate theresponse button 6. - In the event a non-patient presses the
response button 6 in response to alarms, instructions or other prompts directed to thepatient 1, thecontroller 2 may be configured to send additional instructions that are relayed to the patient or bystander as audible output, visual output, or both. For example, if a non-patient improperly presses theresponse button 6, thecontroller 2 may be configured to ensure instructions are directed to the non-patient that informs the non-patient that treatment will soon be offered to the patient or that the non-patient should not press theresponse button 6 and that the non-patient should move away from and not touch thepatient 1. Of course, thecontroller 2 may also be configured to cause other instructions or prompts to be transmitted to a non-patient, patient or both. - The
microcontroller 7 may also be configured to provide audible instructions, visual instructions, or a combination of both audible and visual instructions to apatient 1 or others located near thepatient 1. Themicrocontroller 7 can be connected to an audio speaker or display located on or in a housing of thecontroller 2 or located in another device that is worn by thepatient 1 or connected to thecontroller 2. Thecontroller 2 can be configured so that instructions or prompts are directed toward thepatient 1. For instance, visual instructions may be displayed on the display, such as for example, an LCD display, or other display connected to thecontroller 2. The instructions may also be audibly provided to thepatient 1 as output transmitted by the speaker or other audible output device. - It should be appreciated that alternate embodiments may include a
response button 6 that does not have any mechanical action or functionality. For example, one alternate embodiment may include an actuator affixed to the housing of the controller or an actuator that is integral with the housing of thecontroller 2. For instance, a portion of the controller housing may include indicia identifying the location of abiometric transducer 17 that is integral with that portion of the controller housing so a patient will know where to place a finger or other portion of the patient's body to respond to alarms or other prompts used to ask the patient to verify that the patient is awake and not in need of treatment. - A wearable defibrillator can also be configured to utilize a
falloff signal 14 to determine that thepatient 1 is responding to prompts or instructions and verify that the patient is conscious and not in need of treatment. One embodiment of such a wearable defibrillator is illustrated inFIG. 3 , which shows awearable defibrillator 41 that utilizes afalloff signal 14. A block diagram illustrating the processing of the second present preferred embodiment of thedefibrillator 41 is shown inFIG. 4 . One ormore therapy electrodes 5, or treatment electrodes, are configured to emit a uniquefalloff marker signal 14 into the body of thepatient 1. One or more of thesensors 4 of thedefibrillator 41 are configured to sense thefalloff signal 14. Preferably, thefalloff signal 14 has electrical characteristics that permit the one ormore sensors 4 to also sense other biometric signals, such as, for example, ECG signals and other signals. Thecontroller 2 is configured to detect the existence of thefalloff signal 14. - The
controller 2 may also be configured to detect if asensor 4 has fallen off the body. For example, thecontroller 2 may be configured to determine that asensor 4 has become disconnected from the body of thepatient 1 if thefalloff marker signal 14 is not detected by one of thesensors 4, but is detected byother sensors 4. If thecontroller 2 determines such a condition exists, the controller may be configured to provide one or more prompts or instructions to thepatient 1 to reattach the dislodgedsensor 4. Such a prompt or instruction may be provided on a display connected to thecontroller 2 or a speaker connected to thecontroller 2. - The
controller 2 includes amicrocontroller 7 that is connected to afalloff signal generator 17, thesensors 4, apatient notification circuit 10,defibrillator circuits 9 and asignal processing circuit 8. In some embodiments of the wearable defibrillator, thesignal processing circuit 8,patient notification circuit 10 andmicrocontroller 7 may be located within the housing of thecontroller 2. - The
falloff signal generator 17 is connected to thesensors 4. In other embodiments, the fall offsignal generator 17 may be connected to a separate device worn by thepatient 1, such as, for example, thetreatment electrodes 5. - The
response button 6 includes abiometric detector 18 or other biometric sensor that is configured to receive thefalloff signal 14 from the body of the person contacting the response button. Thesignal processing circuit 8 is configured to determine whether thefalloff signal 14 has been received from thebiometric sensor 18. - The
controller 2 is configured to determine whether theresponse button 6 has been activated and, if so, whether thefalloff signal 14 was received from thebiometric sensor 18. If both thefalloff signal 14 was received and theresponse button 6 was actuated, thecontroller 2 is configured to determine that thepatient 1 actuated theresponse button 6. It should be appreciated that such a determination can be used to verify that apatient 1 is responding to prompts or instructions displayed or played by notification devices such as, for example, a monitor or speaker, connected to thecontroller 2. - A third embodiment of a
wearable defibrillator 51 is illustrated inFIGS. 5, 6 and 7 . Theresponse button 6 of thewearable defibrillator 51 includes an ECG detector 19 that is configured to sense theECG signal 12 of thepatient 1 wearing the defibrillator. The ECG detector 19 may be attached toresponse button 6 such that at least a portion of the detector 19 extends out of the outer surface of theresponse button 6, may be attached on the outer surface of theresponse button 6, or may be otherwise connected to theresponse button 6. Preferably, the ECG detector 19 is an ECG electrode that is similar in design toECG sensors 4 that are attached to thedefibrillator 51. - The
controller 2 of thedefibrillator 51 may be configured to confirm that thepatient 1 is actuating theresponse button 6 by correlating anyECG signal 20 received by the ECG detector 19 with the ECG signals 20, 21 received by theECG sensors 4 worn by thepatient 1. Thecontroller 2 can be configured to compare the ECG signals received by the ECG detector 19 to the ECG signals received by theECG sensors 4 worn by thepatient 1 in various ways. For example, thecontroller 2 may be configured to utilize morphology comparisons, rate comparison, R-wave synchronization or any combination thereof to compare the ECG signals 20, 21 and determine whether the ECG signals 20, 21 received by ECG detector 19 to verify that the person actuating theresponse button 6 is thepatient 1. - It should be appreciated that if a person that is not the patient actuates the
response button 6, a correlating ECG signal should not be detected by thecontroller 2. As illustrated inFIG. 7 , in the event a non patient actuates theresponse button 6, the ECG signal received by the ECG detector 19 will be an ECG signal that is not a match to the patient ECG signal being received by thesensors 4. It should also be appreciated that if a person that is not thepatient 1 does not have a common ground reference to the circuitry of thedefibrillator 51, a corrupt signal or no signal at all may be received by thecontroller 2. Thesignal processing circuit 8 ormicrocontroller 7 can be configured to recognize that the signal received from the ECG detector 19 does not match the signals received from thesensors 4. Thecontroller 2 may be configured to disregard any actuation of theresponse button 6 that thecontroller 2 determines was made by a person that is not thepatient 1. Thecontroller 2 may also be configured to provide prompts or instructions to a non-patient that has actuated a response button to inform the non-patient that he or she should not respond to the prompts, request additional input to verify the person actuating the response button is not thepatient 1, or inform the non-patient that treatment is about to be provided to thepatient 1 and, consequently, that he or she should move away from thepatient 1. - Another embodiment of a wearable defibrillator, illustrated in
FIGS. 8 and 9 , depict a wearable defibrillator 61 configured to verify apatient 1 is actuating aresponse button 6 or actuating some other response mechanism by detecting a capacitance value of the person or object actuating the response button. The capacitance value can be used to verify whether thepatient 1 or some other person has actuated the response mechanism. For example, the measured capacitance value can be compared with a value or range of values related to the patient that are stored in the controller to verify that the patient actuated the response mechanism. The stored capacitance value or range of capacitance values may be stored in thecontroller 2 during the start-up procedure for the defibrillator or may be stored and saved by thecontroller 2 during an initial use of the defibrillator by thepatient 1 and reused by thecontroller 2 until a new value or range of values is saved to thecontroller 2 to replace the old value or range of values. - The
controller 2 of wearable defibrillator 61 includes aresponse button 6 that has acapacitive detector 22 or other capacitive sensor. Preferably, thecapacitive detector 22 is a capacitive type electrode. Thecapacitive detector 22 is connected to atouch sensor 15 or other circuitry that is configured to detect variations incapacitance 23 due to patient specific physical interaction with theresponse button 6 andcapacitive detector 22. As illustrated inFIG. 9 , thecontroller 2 can be configured to determine when theresponse button 6 has been actuated by thepatient 1 by comparing the capacitance value sensed by thecapacitance detector 22 with a capacitance value or range of capacitance values stored in thecontroller 2 or in memory connected to thecontroller 2. If the capacitance value is not within the stored range of values or is not the stored value, thecontroller 2 is configured to determine that thepatient 1 did not actuate theresponse button 6. Thecontroller 2 may be configured to disregard actuation of theresponse button 6 if it is determined that thepatient 1 did not actuate theresponse button 6 and may also be configured to provide one or more prompts or instructions to the non-patient that may have actuated theresponse button 6. - Accessory items may also be used to verify that a patient is providing input to a wearable defibrillator. For example, the embodiment of the wearable defibrillator 71 shown in
FIG. 10 includes one or more accessory items that transmit an identification marker 26 to thecontroller 2 of the defibrillator. The accessory items may be afinger ring 24,bracelet 25, necklace, lanyard, earring, badge, name tag, any other accessory that may be worn by a user or any combination thereof. - The
controller 2 can include one or more receivers or other detectors that are configured to receive the identification marker transmitted by the one or more accessory items. Thecontroller 2 may also be configured to determine when an accessory item is close to the housing of thecontroller 2 or a monitor or other display connected to thecontroller 2. For example, amagnetic proximity detector 27 or other proximity sensor configured to detect one or more of the accessory items may be provided on or connected to thecontroller 2. - The
controller 2 can be configured to utilize the presence of the accessory item to verify that the patient is actuating a response mechanism such as forexample response button 6. Thecontroller 2 may also be configured to verify that all response mechanism actuations are made by a patient during a treatment sequence run or controlled by thecontroller 2. For example, thecontroller 2 can be configured to ignore the actuation of a response mechanism or transmit additional patient prompts, alarms or instructions through a display or speaker connected to thecontroller 2 if a correlating identification accessory is not sensed or is not sensed to be within a certain distance from thecontroller 2 or receiver. - The location of the response mechanism, such as, for example, one or
more response buttons 6 may be sized and configured to avoid accidental activation or a response by someone other than the patient. For instance, the response mechanism may include one or more buttons that are located on the housing of thecontroller 2 in a hidden or obscured location. One example of such a hidden location may be a recessed portion of the controller housing. Another example of such a hidden location may be locating one ormore response buttons 6 under a latch or cover that is moveably connected to the housing of thecontroller 2 or a display connected to thecontroller 2. As yet another example, the response mechanism may be a device that has one or more actuators that are wirelessly connected to thecontroller 2. Such a device may be within the pocket of an article of clothing worn by a patient or positioned in another location a typical passerby would be unlikely to see or find. - It should be appreciated that
multiple response buttons 6, response switches or other response mechanism may be connected to thecontroller 2. Preferably, two or ore response buttons are used such that simultaneous activation of the two or more buttons is required to actuate the response mechanism. Such a configuration can reduce false positive detection. - Of course, actuation of a response mechanism may also include actuating one or more response buttons in a particular sequence. For instance, the
controller 2 or response mechanism may be configured so that actuation of a response mechanism occurs when a patient presses different buttons in a particular sequence or moves one or more response switches or other buttons to different positions. For example, if an embodiment included a response mechanism that had a switch, the response mechanism could be configured so that movement of the switch from a first position to a second position and then back to the first position within a certain time interval was necessary to actuate the response mechanism. - It should be understood that one or more additional sensors may be used to avoid accidental activation or a response by a non-patient. Such additional sensors may include a biometric sensor such as for example a fingerprint, voice, or face recognition sensor. The
controller 2 can be configured to require input from the additional sensor that correlates with patient data stored in thecontroller 2 or stored in memory connected to thecontroller 2 to verify that a patient is actuating a response mechanism or otherwise providing input to thecontroller 2. - Of course, the
controller 2 can also be configured to use other verification methods to provide additional input that confirms a patient is providing input to thecontroller 2. For example, a feedback loop that includes a current path to thecontroller 2 or a current path to a display device connected to thecontroller 2 may also be used to verify that a patient is providing input to thecontroller 2. - One or more additional sensors may also include a motion, position or oximetry detector located on another area of the patient's body and connected to the
controller 2. Thecontroller 2 could be configured to obtain input from such sensors to aid thecontroller 2 in determining the condition of thepatient 1. - Embodiments of a wearable defibrillator may also include a
controller 2 configured to receive a code or password from apatient 1. The password or code may be provided to thecontroller 2 by use of one or more buttons, a key pad, or other data entry device connected to or located on thecontroller 2. Thecontroller 2 could be configured to require entry of the password or code at any time during the sequence of alarms or other prompts or instructions to prevent someone other than the patient from inadvertently giving a response when thepatient 1 is unconscious. Of course, such a code could also include pressing one or more response buttons, one or more response switches, or other response actuators in a certain sequence. - Of course, since the
controller 2 can also be configured to verify that the response mechanism is working properly to avoid or mitigate errors resulting from broken or damaged response mechanisms. In one embodiment, thecontroller 2 can be configured to routinely test the response mechanism for proper functionality or monitor the response mechanism to predict a failure of the response mechanism. For instance, thecontroller 2 can be configured to conduct a response test each time the defibrillator is turned on. In the event thecontroller 2 does not receive input from the response mechanism or otherwise recognize any actuation of the response mechanism during a test of the response mechanism, thecontroller 2 may be configured to provide one or more audible or visual prompts to thepatient 1 that informs thepatient 1 the response mechanism is broken or needs to be repaired. Thecontroller 2 may also be configured to use an alternate responsiveness test method if one is available or inform thepatient 1 that to prevent treatment, it would be necessary to remove the power source from thecontroller 2. Thecontroller 2 may also be configured so that it deactivates the defibrillator after it determines that the response mechanism is not functioning properly. - In the event the
controller 2 is configured to monitor response mechanism operations to predict the failure of the response mechanism, thecontroller 2 may be configured to process a prediction algorithm configured to predict future failure of the response mechanism. When a failure is predicted, thecontroller 2 can be configured to alert thepatient 1, disable the defibrillator, or both. - It should be appreciated that variations of the present preferred embodiments discussed above may be made. For example, embodiments of the wearable defibrillator can be sized and configured to be worn as a harness, belt, vest, or other wearable device. As another example, a response mechanism can include one or more response buttons, response switches, other response actuators or any combination thereof. As yet another example, the
controller 2 of the wearable defibrillator may be connected to different components of the wearable defibrillator by one or more direct or indirect wireless connections, direct or indirect wired connections, or any combination thereof. As yet another example, the treatment electrodes may include various types of treatment electrodes known to those skilled in the art, such as, for example, pulse electrodes disclosed in U.S. Pat. No. 5,078,134. - While certain present preferred embodiments of the wearable defibrillator and certain embodiments of methods of practicing the same have been shown and described, it is to be distinctly understood that the invention is not limited thereto but may be otherwise variously embodied and practiced within the scope of the following claims.
Claims (22)
1-26. (canceled)
27. A wearable defibrillator for communicating with patients and non-patients, comprising:
a sensing electrode configured to sense an electrocardiogram signal of a patient wearing the wearable defibrillator;
a treatment electrode configured to provide a therapeutic shock to the patient wearing the wearable defibrillator;
a response mechanism configured to be actuated by the patient or a non-patient;
a notification circuit; and
a controller that is operatively connected to the sensing electrode, the treatment electrode, the response mechanism, and the notification circuit, the controller being configured to
make a determination that the non-patient actuated the response mechanism; and
in response to making the determination,
provide instructions to the non-patient, via the notification circuit, to refrain from actuating the response mechanism; and/or
provide instructions to the non-patient, via the notification circuit, to move away from the patient because the therapeutic shock will be delivered to the patient.
28. The wearable defibrillator of claim 27 , wherein
the response mechanism is further configured to receive a signal from a body of the patient and/or the non-patient during actuation of the response mechanism; and
the controller is configured to make the determination that the non-patient actuated the response mechanism based at least in part on the signal received from the body of the patient and/or the non-patient.
29. The wearable defibrillator of claim 27 , wherein the controller is further configured to
receive input from the response mechanism in response to actuation of the response mechanism; and
make the determination based at least in part on the input received as a result of actuation of the response mechanism.
30. The wearable defibrillator of claim 27 , wherein the controller is further configured to
make an alternative determination that the patient actuated the response mechanism; and
in response to making the alternative determination, prevent the therapeutic shock from being delivered to the patient.
31. The wearable defibrillator of claim 27 , wherein
the response mechanism is further configured to, in response to being actuated, transmit a marker signal into a body of a person actuating the response mechanism;
the sensing electrode is further configured to detect whether the marker signal is present in a body of the patient; and
the controller is configured to make the determination at least in part in response to the sensing electrode detecting that the marker signal is not present in the body of the patient.
32. The wearable defibrillator of claim 31 , wherein the controller is wirelessly connected to the response mechanism.
33. The wearable defibrillator of claim 31 , wherein the notification circuit includes a display that is operatively connected to the controller, wherein at least some of the instructions are presented on the display.
34. The wearable defibrillator of claim 31 , wherein the notification circuit includes a speaker that is operatively connected to the controller, wherein at least some of the instructions are audibly presented using the speaker.
35. The wearable defibrillator of claim 31 , wherein the marker signal includes encoded information unique to either the patient or the wearable defibrillator.
36. The wearable defibrillator of claim 31 , wherein
the response mechanism comprises a transducer; and
the wearable defibrillator further comprises a signal generator that is coupled to the transducer and that is configured to generate the marker signal.
37. The wearable defibrillator of claim 27 , wherein
the response mechanism comprises a detector configured to determine a capacitance value of a person actuating the response mechanism; and
the controller is further configured to make the determination based at least in part on the determined capacitance value.
38. The wearable defibrillator of claim 37 , wherein the controller is wirelessly connected to the response mechanism.
39. The wearable defibrillator of claim 37 , wherein the notification circuit includes a display that is operatively connected to the controller, wherein at least some of the instructions are presented on the display.
40. The wearable defibrillator of claim 37 , wherein the notification circuit includes a speaker that is operatively connected to the controller, wherein at least some of the instructions are audibly presented using the speaker.
41. The wearable defibrillator of claim 37 , wherein the controller is configured to
compare the determined capacitance value to a range of capacitance values of the patient; and
make the determination in response to determining that the determined capacitance value is outside the range of capacitance values.
42. The wearable defibrillator of claim 27 , wherein
the response mechanism includes a detector configured to receive an electrocardiogram signal of a person actuating the response mechanism; and
the controller is configured to make the determination based at least in part on a comparison of the electrocardiogram signal of the patient with the electrocardiogram signal of the person actuating the response mechanism.
43. The wearable defibrillator of claim 42 , wherein the controller is wirelessly connected to the response mechanism.
44. The wearable defibrillator of claim 42 , wherein the notification circuit includes a display that is operatively connected to the controller, wherein at least some of the instructions are presented on the display.
45. The wearable defibrillator of claim 42 , wherein the notification circuit includes a speaker that is operatively connected to the controller, wherein at least some of the instructions are audibly presented using the speaker.
46. The wearable defibrillator of claim 42 , wherein the comparison uses at least one of morphology comparisons, rate comparisons, and R-wave synchronizations.
47. The wearable defibrillator of claim 27 , wherein the controller is further configured to provide instructions to the patient, via the notification circuit, to actuate the response mechanism to prevent the therapeutic shock from being provided to the patient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/455,235 US20220072323A1 (en) | 2007-06-07 | 2021-11-17 | Medical device configured to test for user responsiveness |
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93355007P | 2007-06-07 | 2007-06-07 | |
US12/150,720 US8271082B2 (en) | 2007-06-07 | 2008-04-30 | Medical device configured to test for user responsiveness |
US13/612,400 US9370666B2 (en) | 2007-06-07 | 2012-09-12 | Medical device configured to test for user responsiveness |
US14/876,322 US10328275B2 (en) | 2007-06-07 | 2015-10-06 | Medical device configured to test for user responsiveness |
US15/205,542 US10434321B2 (en) | 2007-06-07 | 2016-07-08 | Medical device configured to test for user responsiveness |
US16/546,655 US11207539B2 (en) | 2007-06-07 | 2019-08-21 | Medical device configured to test for user responsiveness |
US17/455,235 US20220072323A1 (en) | 2007-06-07 | 2021-11-17 | Medical device configured to test for user responsiveness |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/546,655 Continuation US11207539B2 (en) | 2007-06-07 | 2019-08-21 | Medical device configured to test for user responsiveness |
Publications (1)
Publication Number | Publication Date |
---|---|
US20220072323A1 true US20220072323A1 (en) | 2022-03-10 |
Family
ID=40011399
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/150,720 Active 2031-03-21 US8271082B2 (en) | 2007-06-07 | 2008-04-30 | Medical device configured to test for user responsiveness |
US13/612,400 Active US9370666B2 (en) | 2007-06-07 | 2012-09-12 | Medical device configured to test for user responsiveness |
US14/876,322 Active US10328275B2 (en) | 2007-06-07 | 2015-10-06 | Medical device configured to test for user responsiveness |
US15/205,542 Active US10434321B2 (en) | 2007-06-07 | 2016-07-08 | Medical device configured to test for user responsiveness |
US16/546,655 Active 2028-09-10 US11207539B2 (en) | 2007-06-07 | 2019-08-21 | Medical device configured to test for user responsiveness |
US17/455,235 Pending US20220072323A1 (en) | 2007-06-07 | 2021-11-17 | Medical device configured to test for user responsiveness |
Family Applications Before (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/150,720 Active 2031-03-21 US8271082B2 (en) | 2007-06-07 | 2008-04-30 | Medical device configured to test for user responsiveness |
US13/612,400 Active US9370666B2 (en) | 2007-06-07 | 2012-09-12 | Medical device configured to test for user responsiveness |
US14/876,322 Active US10328275B2 (en) | 2007-06-07 | 2015-10-06 | Medical device configured to test for user responsiveness |
US15/205,542 Active US10434321B2 (en) | 2007-06-07 | 2016-07-08 | Medical device configured to test for user responsiveness |
US16/546,655 Active 2028-09-10 US11207539B2 (en) | 2007-06-07 | 2019-08-21 | Medical device configured to test for user responsiveness |
Country Status (4)
Country | Link |
---|---|
US (6) | US8271082B2 (en) |
JP (3) | JP5492388B2 (en) |
DE (1) | DE102008025709B4 (en) |
FR (1) | FR2916982B1 (en) |
Families Citing this family (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8369944B2 (en) | 2007-06-06 | 2013-02-05 | Zoll Medical Corporation | Wearable defibrillator with audio input/output |
US8271082B2 (en) | 2007-06-07 | 2012-09-18 | Zoll Medical Corporation | Medical device configured to test for user responsiveness |
US7974689B2 (en) * | 2007-06-13 | 2011-07-05 | Zoll Medical Corporation | Wearable medical treatment device with motion/position detection |
US8140154B2 (en) | 2007-06-13 | 2012-03-20 | Zoll Medical Corporation | Wearable medical treatment device |
US20100311482A1 (en) * | 2009-05-30 | 2010-12-09 | Lange Daniel H | Electro-Biometric Methods and Apparatus |
CN105054924A (en) | 2010-05-18 | 2015-11-18 | 佐尔医药公司 | Wearable ambulatory medical device with multiple sensing electrodes |
PL2571572T3 (en) | 2010-05-18 | 2017-05-31 | Zoll Medical Corporation | Wearable therapeutic device |
US10493289B2 (en) | 2010-07-09 | 2019-12-03 | Zoll Medical Corporation | System and method for conserving power in a medical device |
US9937355B2 (en) * | 2010-11-08 | 2018-04-10 | Zoll Medical Corporation | Remote medical device alarm |
WO2012078857A2 (en) | 2010-12-09 | 2012-06-14 | Zoll Medical Corporation | Electrode with redundant impedance reduction |
BR112013014219A2 (en) | 2010-12-10 | 2016-09-13 | Zoll Medical Corp | therapeutic device |
US9427564B2 (en) * | 2010-12-16 | 2016-08-30 | Zoll Medical Corporation | Water resistant wearable medical device |
RU2633472C2 (en) * | 2011-01-27 | 2017-10-12 | Конинклейке Филипс Электроникс Н.В. | Clamping defibrillator electrodes with illuminated discharge buttons |
US9684767B2 (en) | 2011-03-25 | 2017-06-20 | Zoll Medical Corporation | System and method for adapting alarms in a wearable medical device |
US8897860B2 (en) | 2011-03-25 | 2014-11-25 | Zoll Medical Corporation | Selection of optimal channel for rate determination |
EP2689363B1 (en) | 2011-03-25 | 2022-07-27 | Zoll Medical Corporation | System and method for adapting alarms in a wearable medical device |
US8600486B2 (en) | 2011-03-25 | 2013-12-03 | Zoll Medical Corporation | Method of detecting signal clipping in a wearable ambulatory medical device |
WO2012151160A1 (en) | 2011-05-02 | 2012-11-08 | Zoll Medical Corporation | Patient-worn energy delivery apparatus and techniques for sizing same |
CN103764222B (en) | 2011-09-01 | 2016-02-10 | 佐尔医药公司 | Wearable monitoring and therapeutic equipment |
EP3610919A1 (en) | 2012-03-02 | 2020-02-19 | Zoll Medical Corporation | A system comprising a wearable therapeutic device |
CN104870050A (en) | 2012-05-31 | 2015-08-26 | 佐尔医药公司 | Medical monitoring and treatment device with external pacing |
US10328266B2 (en) | 2012-05-31 | 2019-06-25 | Zoll Medical Corporation | External pacing device with discomfort management |
WO2013181607A1 (en) | 2012-05-31 | 2013-12-05 | Zoll Medical Corporation | Systems and methods for detecting health disorders |
US11097107B2 (en) | 2012-05-31 | 2021-08-24 | Zoll Medical Corporation | External pacing device with discomfort management |
US20140025131A1 (en) * | 2012-07-20 | 2014-01-23 | Physio-Control, Inc. | Wearable defibrillator with voice prompts and voice recognition |
FR2994098B1 (en) * | 2012-08-06 | 2020-02-21 | Pierre Henri Cadet | COMMUNICATING DEFIBRILLATOR DEVICE |
US9999393B2 (en) | 2013-01-29 | 2018-06-19 | Zoll Medical Corporation | Delivery of electrode gel using CPR puck |
US10049336B2 (en) | 2013-02-14 | 2018-08-14 | Sociometric Solutions, Inc. | Social sensing and behavioral analysis system |
US9443521B1 (en) | 2013-02-14 | 2016-09-13 | Sociometric Solutions, Inc. | Methods for automatically analyzing conversational turn-taking patterns |
US8880196B2 (en) | 2013-03-04 | 2014-11-04 | Zoll Medical Corporation | Flexible therapy electrode |
US9827431B2 (en) | 2013-04-02 | 2017-11-28 | West Affum Holdings Corp. | Wearable defibrillator with no long-term ECG monitoring |
US10016613B2 (en) | 2013-04-02 | 2018-07-10 | West Affum Holdings Corp. | Wearable cardiac defibrillator system long-term monitoring alternating patient parameters other than ECG |
CA2913538C (en) * | 2013-06-07 | 2022-01-04 | Sociometric Solutions, Inc. | Social sensing and behavioral analysis system |
EP3932478A1 (en) | 2013-06-28 | 2022-01-05 | Zoll Medical Corporation | Ambulatory medical device capable of delivering therapy to a patient |
US20150039042A1 (en) * | 2013-08-01 | 2015-02-05 | Zoll Medical Corporation | Indicators on a Wearable Medical Therapy Device |
EP3027274A4 (en) | 2013-08-01 | 2017-04-26 | Zoll Medical Corporation | Systems and methods for utilizing identification devices in a wearable medical therapy device |
WO2015056262A1 (en) * | 2013-10-18 | 2015-04-23 | Healthwatch Ltd. | Independent wearable health monitoring system, adapted to interface with a treatment device |
WO2015123198A1 (en) | 2014-02-12 | 2015-08-20 | Zoll Medical Corporation | System and method for adapting alarms in a wearable medical device |
CN105960575B (en) * | 2014-02-24 | 2018-06-12 | 索尼公司 | Power consumption and the intelligent wearable device and method of network load optimization |
WO2015127466A2 (en) | 2014-02-24 | 2015-08-27 | Element Science, Inc | External defibrillator |
US9352166B2 (en) * | 2014-03-19 | 2016-05-31 | West Affum Holdings Corp. | Wearable cardiac defibrillator system sounding to bystanders in patient's own voice |
US20180116537A1 (en) | 2014-07-07 | 2018-05-03 | Zoll Medical Corporation | System and Method for Distinguishing a Cardiac Event From Noise in an Electrocardiogram (ECG) Signal |
EP3166482B1 (en) | 2014-07-07 | 2019-09-25 | Zoll Medical Corporation | System and method for distinguishing a cardiac event from noise in an electrocardiogram (ecg) signal |
WO2016077786A1 (en) | 2014-11-14 | 2016-05-19 | Zoll Medical Corporation | Medical premonitory event estimation |
US9902028B2 (en) | 2014-11-20 | 2018-02-27 | Zoll Medical Corporation | External case for a wearable medical device |
WO2016085433A1 (en) * | 2014-11-25 | 2016-06-02 | Orhan Umut | Automated electroshock wristband |
WO2016100906A1 (en) | 2014-12-18 | 2016-06-23 | Zoll Medical Corporation | Pacing device with acoustic sensor |
MX2017008602A (en) * | 2014-12-30 | 2017-11-15 | Koninklijke Philips Nv | Advanced warning indicator for emergency medcial devices. |
EP4218551A3 (en) | 2015-02-27 | 2023-08-09 | Zoll Medical Corporation | Downloading and booting method and system for a wearable medical device |
US10321877B2 (en) | 2015-03-18 | 2019-06-18 | Zoll Medical Corporation | Medical device with acoustic sensor |
US10272010B2 (en) | 2015-03-20 | 2019-04-30 | Zoll Medical Corporation | Systems and methods for testing a medical device |
US10835449B2 (en) | 2015-03-30 | 2020-11-17 | Zoll Medical Corporation | Modular components for medical devices |
US10127357B2 (en) | 2015-05-18 | 2018-11-13 | Zoll Medical Corporation | Mobile monitoring and patient management system |
US10578677B2 (en) | 2015-06-30 | 2020-03-03 | Zoll Medical Corporation | Systems and methods for monitoring battery life status |
US9839356B2 (en) | 2015-07-07 | 2017-12-12 | Zoll Medical Corporation | Systems and methods for communicating data |
US10953234B2 (en) | 2015-08-26 | 2021-03-23 | Element Science, Inc. | Wearable devices |
US10252070B2 (en) | 2015-09-08 | 2019-04-09 | Zoll Medical Corporation | Secure limited components for use with medical devices |
US11364389B2 (en) | 2015-10-01 | 2022-06-21 | Zoll Medical Corporation | Training modules for an external medical device |
CN108136194B (en) | 2015-11-23 | 2021-10-26 | Zoll医疗公司 | Garment for wearable medical device |
US11116426B2 (en) | 2015-12-09 | 2021-09-14 | Zoll Medical Corporation | Device administered tests and adaptive interactions |
US11064952B2 (en) | 2015-12-30 | 2021-07-20 | Zoll Medical Corporation | External medical device that identifies a response activity |
US11709747B2 (en) | 2016-01-08 | 2023-07-25 | Zoll Medical Corporation | Patient assurance system and method |
US10561852B2 (en) * | 2016-02-26 | 2020-02-18 | Zoll Medical Corporation | Systems and methods for providing rapid medical care |
US11617538B2 (en) | 2016-03-14 | 2023-04-04 | Zoll Medical Corporation | Proximity based processing systems and methods |
US10674911B2 (en) | 2016-03-30 | 2020-06-09 | Zoll Medical Corporation | Systems and methods of integrating ambulatory medical devices |
US11508474B2 (en) | 2016-03-31 | 2022-11-22 | Zoll Medical Corporation | Event reconstruction for a medical device |
US10426342B2 (en) | 2016-03-31 | 2019-10-01 | Zoll Medical Corporation | Remote access for ambulatory medical device |
US10149981B2 (en) | 2016-05-03 | 2018-12-11 | Cardiac Pacemakers, Inc. | Authentication of shock therapy deferral |
US10632301B2 (en) | 2016-09-30 | 2020-04-28 | Zoll Medical Corporation | Medical device connector for coupling electrodes |
US11672484B2 (en) | 2016-12-16 | 2023-06-13 | Zoll Medical Corporation | Electrode falloff detection |
US11213691B2 (en) | 2017-02-27 | 2022-01-04 | Zoll Medical Corporation | Ambulatory medical device interaction |
US11009870B2 (en) | 2017-06-06 | 2021-05-18 | Zoll Medical Corporation | Vehicle compatible ambulatory defibrillator |
WO2019075035A1 (en) | 2017-10-12 | 2019-04-18 | Zoll Medical Corporation | System and method for distinguishing a cardiac event from noise in an electrocardiogram (ecg) signal |
US10646707B2 (en) | 2017-11-30 | 2020-05-12 | Zoll Medical Corporation | Medical devices with rapid sensor recovery |
US10960213B2 (en) | 2018-03-12 | 2021-03-30 | Zoll Medical Corporation | Verification of cardiac arrhythmia prior to therapeutic stimulation |
US10602945B2 (en) | 2018-03-13 | 2020-03-31 | Zoll Medical Corporation | Telemetry of wearable medical device information to secondary medical device or system |
EP3764886B1 (en) | 2018-03-16 | 2024-01-10 | ZOLL Medical Corporation | Monitoring physiological status based on bio-vibrational and radio frequency data analysis |
WO2019246086A1 (en) | 2018-06-18 | 2019-12-26 | Zoll Medical Corporation | Medical device for estimating risk of patient deterioration |
US10918877B2 (en) | 2018-09-28 | 2021-02-16 | Zoll Medical Corporation | Battery lock for ambulatory medical device |
US11568984B2 (en) | 2018-09-28 | 2023-01-31 | Zoll Medical Corporation | Systems and methods for device inventory management and tracking |
US11890461B2 (en) | 2018-09-28 | 2024-02-06 | Zoll Medical Corporation | Adhesively coupled wearable medical device |
US11253715B2 (en) | 2018-10-10 | 2022-02-22 | Element Science, Inc. | Wearable medical device with disposable and reusable components |
US11642539B2 (en) * | 2018-12-21 | 2023-05-09 | Zoll Medical Corporation | Response mechanisms |
US11590354B2 (en) * | 2018-12-28 | 2023-02-28 | Zoll Medical Corporation | Wearable medical device response mechanisms and methods of use |
CN112642061A (en) | 2019-10-09 | 2021-04-13 | Zoll医疗公司 | Modular electrotherapy device |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030004547A1 (en) * | 1997-03-07 | 2003-01-02 | Owen James M. | Defibrillation system |
US20060116724A1 (en) * | 2002-12-13 | 2006-06-01 | David Snyder | External defibrillator with shock activated by cessation of precordial compressions |
US20180153765A1 (en) * | 2011-04-08 | 2018-06-07 | Zoll Medical Corporation | System for Assisting Rescuers in Performing Cardio-Pulmonary Resuscitation (CPR) on a Patient |
Family Cites Families (172)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5115450A (en) | 1974-07-29 | 1976-02-06 | Ritsuo Hasumi | HIKARIDENSOFUAIBAANO HANSHAFUIRUTA |
DE2644236C3 (en) | 1976-09-30 | 1981-04-02 | Siemens AG, 1000 Berlin und 8000 München | Electrode for taking physiological signals |
US4094310A (en) * | 1976-10-04 | 1978-06-13 | American Optical Corporation | Apparatus for enhanced display of physiological waveforms and for defibrillation |
US4632122A (en) | 1985-04-24 | 1986-12-30 | Johansson Nils E | Method and apparatus for conducting brain function diagnostic test |
IT1208223B (en) | 1987-06-18 | 1989-06-12 | Sgs Microelettronica Spa | HIGH DYNAMIC APPLICATION STAGE WITH DISTORTION DETECTION. |
US4869254A (en) | 1988-03-30 | 1989-09-26 | Nellcor Incorporated | Method and apparatus for calculating arterial oxygen saturation |
US4928690A (en) * | 1988-04-25 | 1990-05-29 | Lifecor, Inc. | Portable device for sensing cardiac function and automatically delivering electrical therapy |
US5078134A (en) | 1988-04-25 | 1992-01-07 | Lifecor, Inc. | Portable device for sensing cardiac function and automatically delivering electrical therapy |
US5062834A (en) | 1989-02-24 | 1991-11-05 | Product Development (S.G.Z.) Ltd | Device for dispensing a liquid particularly useful for delivering medicaments at a predetermined rate |
US4978926A (en) | 1989-12-21 | 1990-12-18 | Ford Motor Company | Audio limiter using voltage multiplexed feedback |
JP2765602B2 (en) | 1991-10-30 | 1998-06-18 | 日本電気株式会社 | Auto drift cancellation circuit of ECG analyzer |
US5353793A (en) | 1991-11-25 | 1994-10-11 | Oishi-Kogyo Company | Sensor apparatus |
US5342404A (en) * | 1992-04-03 | 1994-08-30 | Intermedics, Inc. | Implantable medical interventional device |
AU1796595A (en) | 1992-12-01 | 1995-07-13 | Siemens Aktiengesellschaft | Cardiac arrhythmia detection system for an implantable stimulation device |
ITMI931761A1 (en) * | 1993-08-03 | 1995-02-03 | Healtech Sa | INFORMATION SUPPORT DEVICE THAT CAN BE ASSOCIATED WITH OUTPATIENT OR HOSPITAL PATIENTS FOR THEIR AUTOMATIC IDENTIFICATION AND |
US5365932A (en) | 1993-09-02 | 1994-11-22 | Telectronics Pacing System, Inc. | Cardiac signal sensing device having sensitivity automatically controlled in response to metabolic demand |
US5738102A (en) * | 1994-03-31 | 1998-04-14 | Lemelson; Jerome H. | Patient monitoring system |
US5652570A (en) | 1994-05-19 | 1997-07-29 | Lepkofker; Robert | Individual location system |
US5752976A (en) | 1995-06-23 | 1998-05-19 | Medtronic, Inc. | World wide patient location and data telemetry system for implantable medical devices |
US5645571B1 (en) | 1995-08-01 | 1999-08-24 | Surviva Link Corp | Automated external defibrillator with lid activated self-test system |
US5662689A (en) | 1995-09-08 | 1997-09-02 | Medtronic, Inc. | Method and apparatus for alleviating cardioversion shock pain |
US6016445A (en) * | 1996-04-16 | 2000-01-18 | Cardiotronics | Method and apparatus for electrode and transthoracic impedance estimation |
US6280461B1 (en) | 1996-05-23 | 2001-08-28 | Lifecor, Inc. | Patient-worn energy delivery apparatus |
US5741306A (en) | 1996-05-23 | 1998-04-21 | Lifecor, Inc. | Patient-worn energy delivery apparatus |
US6169397B1 (en) | 1997-08-13 | 2001-01-02 | University Technology Corp. | Damped superconducting coil system having a multiturn, planar geometry superconducting coil and shunt resistors electrically connecting successive coil turns |
US5944669A (en) | 1997-11-20 | 1999-08-31 | Lifecor, Inc. | Apparatus and method for sensing cardiac function |
US6169387B1 (en) | 1997-12-22 | 2001-01-02 | Lifecor, Inc. | Battery management apparatus for portable electronic devices |
US5929601A (en) | 1997-12-22 | 1999-07-27 | Lifecor, Inc. | Battery management apparatus for portable electronic devices |
US6065154A (en) | 1998-04-07 | 2000-05-23 | Lifecor, Inc. | Support garments for patient-worn energy delivery apparatus |
US5999851A (en) * | 1998-04-15 | 1999-12-07 | Cardiac Pacemakers, Inc. | Atrial defibrillation system having patient selectable atrial fibrillation detection |
US6128521A (en) | 1998-07-10 | 2000-10-03 | Physiometrix, Inc. | Self adjusting headgear appliance using reservoir electrodes |
US7088233B2 (en) | 1998-10-23 | 2006-08-08 | Royal Thoughts, Llc | Personal medical device communication system and method |
US6390996B1 (en) | 1998-11-09 | 2002-05-21 | The Johns Hopkins University | CPR chest compression monitor |
US6097987A (en) | 1998-12-30 | 2000-08-01 | Medical Research Laboratories, Inc. | External defibrillator electrode apparatus |
US6398744B2 (en) * | 1999-03-05 | 2002-06-04 | Revivant Corporation | Public access CPR and AED device |
DE19930263A1 (en) | 1999-06-25 | 2000-12-28 | Biotronik Mess & Therapieg | Method and device for data transmission between an electromedical implant and an external device |
US6221010B1 (en) | 1999-07-02 | 2001-04-24 | Donald A. Lucas | Home medical supervision and monitoring system |
US6253099B1 (en) | 1999-08-19 | 2001-06-26 | Lifecor, Inc. | Cardiac monitoring electrode apparatus and method |
US20030095648A1 (en) * | 1999-10-05 | 2003-05-22 | Lifecor, Inc. | Fault-tolerant remote reprogramming for a patient-worn medical device |
US6681003B2 (en) | 1999-10-05 | 2004-01-20 | Lifecor, Inc. | Data collection and system management for patient-worn medical devices |
US6406426B1 (en) | 1999-11-03 | 2002-06-18 | Criticare Systems | Medical monitoring and alert system for use with therapeutic devices |
US6736759B1 (en) | 1999-11-09 | 2004-05-18 | Paragon Solutions, Llc | Exercise monitoring system and methods |
US6336903B1 (en) * | 1999-11-16 | 2002-01-08 | Cardiac Intelligence Corp. | Automated collection and analysis patient care system and method for diagnosing and monitoring congestive heart failure and outcomes thereof |
US6602191B2 (en) | 1999-12-17 | 2003-08-05 | Q-Tec Systems Llp | Method and apparatus for health and disease management combining patient data monitoring with wireless internet connectivity |
US6405082B1 (en) | 2000-01-24 | 2002-06-11 | Koninklijke Philips Electronics N.V. | Method and apparatus for distinguishing between therapy modes in a defibrillator |
AU2001234846A1 (en) | 2000-02-04 | 2001-08-14 | Zmd Corporation | Integrated resuscitation |
US20050131465A1 (en) | 2000-02-04 | 2005-06-16 | Freeman Gary A. | Integrated resuscitation |
WO2001075513A1 (en) | 2000-04-03 | 2001-10-11 | Massachusetts Institute Of Technology | All optical switch for optical integrated circuits |
IL137045A0 (en) | 2000-06-27 | 2001-06-14 | Gorenberg Nora Viviana | A non-invasive method and apparatus for measuring the mechanical performance of the heart |
US6834436B2 (en) * | 2001-02-23 | 2004-12-28 | Microstrain, Inc. | Posture and body movement measuring system |
US6618617B2 (en) * | 2001-04-20 | 2003-09-09 | Cardiac Pacemakers, Inc. | Delay to therapy following patient controlled atrial shock therapy request |
KR100422294B1 (en) * | 2001-06-28 | 2004-03-12 | 한국과학기술연구원 | Passivation of HgCdTe Junction Diode By Annealing In Cd/Hg Atmosphere |
US6804554B2 (en) * | 2001-10-19 | 2004-10-12 | Medtronic, Inc. | Arrangement and system for enabling patient control of electrical therapies |
US6755795B2 (en) | 2001-10-26 | 2004-06-29 | Koninklijke Philips Electronics N.V. | Selectively applied wearable medical sensors |
US7392085B2 (en) | 2001-11-21 | 2008-06-24 | Cameron Health, Inc. | Multiple electrode vectors for implantable cardiac treatment devices |
US6980112B2 (en) | 2002-01-08 | 2005-12-27 | International Business Machines Corporation | Emergency call patient locating system for implanted automatic defibrillators |
US20030149462A1 (en) | 2002-02-04 | 2003-08-07 | White Sheldon S. | Medical electrodes |
US20030158593A1 (en) | 2002-02-19 | 2003-08-21 | Heilman Marlin S. | Cardiac garment |
US20030174049A1 (en) * | 2002-03-18 | 2003-09-18 | Precision Dynamics Corporation | Wearable identification appliance that communicates with a wireless communications network such as bluetooth |
US6990373B2 (en) | 2002-04-10 | 2006-01-24 | Medtronic Emergency Response Systems, Inc. | Automated external defibrillator with user interface for adult and pediatric applications |
US7120488B2 (en) | 2002-05-07 | 2006-10-10 | Medtronic Physio-Control Manufacturing Corp. | Therapy-delivering portable medical device capable of triggering and communicating with an alarm system |
US7991460B2 (en) | 2002-09-20 | 2011-08-02 | Angel Medical Systems, Inc. | Methods and apparatus for detecting cardiac events based on heart rate sensitive parameters |
US6609023B1 (en) | 2002-09-20 | 2003-08-19 | Angel Medical Systems, Inc. | System for the detection of cardiac events |
US6827695B2 (en) * | 2002-10-25 | 2004-12-07 | Revivant Corporation | Method of determining depth of compressions during cardio-pulmonary resuscitation |
US7149579B1 (en) * | 2002-12-23 | 2006-12-12 | Pacesetter, Inc. | System and method for determining patient posture based on 3-D trajectory using an implantable medical device |
US20040204743A1 (en) | 2003-01-14 | 2004-10-14 | Mcgrath Thomas J. | Remotely operating external medical devices |
AU2004207534A1 (en) | 2003-01-27 | 2004-08-12 | Cardiac Telecom, Corporation | Defibrillation system for non-medical environments |
US7805190B2 (en) * | 2003-04-02 | 2010-09-28 | Physio-Control, Inc. | Defibrillators customized for anticipated patients |
US7460899B2 (en) | 2003-04-23 | 2008-12-02 | Quiescent, Inc. | Apparatus and method for monitoring heart rate variability |
US20040215244A1 (en) * | 2003-04-23 | 2004-10-28 | Marcovecchio Alan F. | Processing pulse signal in conjunction with ECG signal to detect pulse in external defibrillation |
US7427921B2 (en) | 2003-05-21 | 2008-09-23 | Koninklijke Philips Electronics N.V. | Monitoring system capable of generating audible messages |
US8214043B2 (en) | 2006-08-29 | 2012-07-03 | Matos Jeffrey A | Control of a defibrillator and/or pacemaker |
US7831303B2 (en) * | 2003-06-17 | 2010-11-09 | Medtronic, Inc. | Cardiac pacing apparatus and method for continuous capture management |
US7220235B2 (en) * | 2003-06-27 | 2007-05-22 | Zoll Medical Corporation | Method and apparatus for enhancement of chest compressions during CPR |
US20050049515A1 (en) * | 2003-07-31 | 2005-03-03 | Dale Julian Misczynski | Electrode belt for acquisition, processing and transmission of cardiac (ECG) signals |
US7453354B2 (en) * | 2003-10-17 | 2008-11-18 | Koninklijke Philips Electronics, N.V. | Device arranged for carrying out a bioelectrical interaction with an individual and a method for on-demand lead-off detection |
US20070162075A1 (en) | 2004-02-19 | 2007-07-12 | Koninklijke Philips Electronics N.V. | Method and apparatus for broadcasting audible information prompts from an external defibrillator |
EP1720446B1 (en) | 2004-02-27 | 2010-07-14 | Koninklijke Philips Electronics N.V. | Wearable wireless device for monitoring, analyzing and communicating physiological status |
US7878198B2 (en) * | 2004-03-31 | 2011-02-01 | Michael Farrell | Methods and apparatus for monitoring the cardiovascular condition of patients with sleep disordered breathing |
US20050261598A1 (en) | 2004-04-07 | 2005-11-24 | Triage Wireless, Inc. | Patch sensor system for measuring vital signs |
US20050246199A1 (en) | 2004-05-03 | 2005-11-03 | Tom Futch | Health and wellness station |
US7565197B2 (en) * | 2004-06-18 | 2009-07-21 | Medtronic, Inc. | Conditional requirements for remote medical device programming |
US7277756B2 (en) * | 2004-08-16 | 2007-10-02 | Cardiac Pacemakers, Inc. | Risk of death indicator |
US9820658B2 (en) | 2006-06-30 | 2017-11-21 | Bao Q. Tran | Systems and methods for providing interoperability among healthcare devices |
US20060064134A1 (en) | 2004-09-17 | 2006-03-23 | Cardiac Pacemakers, Inc. | Systems and methods for deriving relative physiologic measurements |
US7865236B2 (en) | 2004-10-20 | 2011-01-04 | Nervonix, Inc. | Active electrode, bio-impedance based, tissue discrimination system and methods of use |
AU2005302463A1 (en) | 2004-11-02 | 2006-05-11 | Custom Lab Software Systems, Inc. | Assistive communication device |
JP2008518708A (en) | 2004-11-08 | 2008-06-05 | イデシア・リミテッド | Method and apparatus for electronic biometric identification recognition |
WO2006061762A2 (en) * | 2004-12-08 | 2006-06-15 | Koninklijke Philips Electronics N.V. | Heart defibrillator with contactless ecg sensor for diagnostics/effectivity feedback |
WO2006069215A2 (en) | 2004-12-21 | 2006-06-29 | Ebr Systems, Inc. | Leadless cardiac system for pacing and arrhythmia treatment |
US7324802B2 (en) | 2005-01-20 | 2008-01-29 | Cisco Technology, Inc. | Method and system for managing communication in emergency communication system |
US8185199B2 (en) | 2005-02-10 | 2012-05-22 | Zoll Medical Corporation | Monitoring physiological signals during external electrical stimulation |
CN101184525A (en) * | 2005-03-25 | 2008-05-21 | Zoll医疗公司 | Integrated resuscitation |
US7340296B2 (en) * | 2005-05-18 | 2008-03-04 | Cardiac Pacemakers, Inc. | Detection of pleural effusion using transthoracic impedance |
WO2007019325A2 (en) | 2005-08-04 | 2007-02-15 | Access Cardiosystems, Inc. | Automatic external defibrillator (aed) with wireless communications |
US20070106126A1 (en) | 2005-09-30 | 2007-05-10 | Mannheimer Paul D | Patient monitoring alarm escalation system and method |
DE102005054778B4 (en) | 2005-11-15 | 2009-05-07 | Metrax Gmbh | Automatic external defibrillator device |
US8366641B2 (en) * | 2005-11-18 | 2013-02-05 | Cardiac Pacemakers, Inc. | Posture detector calibration and use |
CN101313307A (en) | 2005-11-23 | 2008-11-26 | 皇家飞利浦电子股份有限公司 | Method and apparatus for remote patient monitoring |
US8046069B2 (en) | 2005-12-22 | 2011-10-25 | Cardiac Pacemakers, Inc. | Method and apparatus for control of cardiac therapy using non-invasive hemodynamic sensor |
US20070162390A1 (en) | 2005-12-22 | 2007-07-12 | Macrovision Corporation | Techniques for distributing and monitoring content |
US7496409B2 (en) | 2006-03-29 | 2009-02-24 | Medtronic, Inc. | Implantable medical device system and method with signal quality monitoring and response |
US7734345B2 (en) | 2006-03-29 | 2010-06-08 | Medtronic, Inc. | Method and system for aborting cardiac treatments |
US20070265671A1 (en) | 2006-04-27 | 2007-11-15 | Roberts Jonathan P | Selectable switching of implantable sensors to provide fault toleance for implantable medical devices |
US9060683B2 (en) | 2006-05-12 | 2015-06-23 | Bao Tran | Mobile wireless appliance |
US7558622B2 (en) | 2006-05-24 | 2009-07-07 | Bao Tran | Mesh network stroke monitoring appliance |
US8475387B2 (en) * | 2006-06-20 | 2013-07-02 | Adidas Ag | Automatic and ambulatory monitoring of congestive heart failure patients |
US8200317B2 (en) | 2006-06-30 | 2012-06-12 | Intel Corporation | Method and apparatus for amplifying multiple signals using a single multiplexed amplifier channel with software controlled AC response |
US20080027499A1 (en) * | 2006-07-28 | 2008-01-31 | Muralidharan Srivathsa | Integrated health care home communication and monitoring system |
US8903477B2 (en) | 2006-07-29 | 2014-12-02 | Lior Berkner | Device for mobile electrocardiogram recording |
US20080030656A1 (en) * | 2006-08-01 | 2008-02-07 | 3M Innovative Properties Company | Transflective lc display with internal reflector and reflective polarizer |
US8024037B2 (en) * | 2006-08-01 | 2011-09-20 | Kumar Uday N | External defibrillator |
US8102842B2 (en) * | 2006-08-04 | 2012-01-24 | Broadcom Corporation | Integrated switch |
US20080177341A1 (en) | 2006-10-27 | 2008-07-24 | Bowers Kyle R | Automated external defibrillator (AED) system with multiple patient wireless monitoring capability for use in mass casualty incidents |
US20080103402A1 (en) | 2006-10-30 | 2008-05-01 | Medtronic Emergency Response Systems, Inc. | Motion detection system for an external defibrillator |
US20090093687A1 (en) | 2007-03-08 | 2009-04-09 | Telfort Valery G | Systems and methods for determining a physiological condition using an acoustic monitor |
US20080249591A1 (en) * | 2007-04-06 | 2008-10-09 | Northstar Neuroscience, Inc. | Controllers for implantable medical devices, and associated methods |
US8750971B2 (en) | 2007-05-24 | 2014-06-10 | Bao Tran | Wireless stroke monitoring |
US8369944B2 (en) * | 2007-06-06 | 2013-02-05 | Zoll Medical Corporation | Wearable defibrillator with audio input/output |
US8271082B2 (en) | 2007-06-07 | 2012-09-18 | Zoll Medical Corporation | Medical device configured to test for user responsiveness |
US7974689B2 (en) * | 2007-06-13 | 2011-07-05 | Zoll Medical Corporation | Wearable medical treatment device with motion/position detection |
US8140154B2 (en) | 2007-06-13 | 2012-03-20 | Zoll Medical Corporation | Wearable medical treatment device |
US20090005827A1 (en) | 2007-06-26 | 2009-01-01 | David Weintraub | Wearable defibrillator |
WO2009034506A1 (en) | 2007-09-12 | 2009-03-19 | Koninklijke Philips Electronics, N.V. | Remote status indicator for a defibrillator |
US20090076349A1 (en) * | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Adherent Multi-Sensor Device with Implantable Device Communication Capabilities |
WO2009036326A1 (en) * | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Adherent athletic monitor |
WO2009036348A1 (en) * | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Medical device automatic start-up upon contact to patient tissue |
US8790257B2 (en) * | 2007-09-14 | 2014-07-29 | Corventis, Inc. | Multi-sensor patient monitor to detect impending cardiac decompensation |
WO2009036313A1 (en) * | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Adherent device with multiple physiological sensors |
US8460189B2 (en) * | 2007-09-14 | 2013-06-11 | Corventis, Inc. | Adherent cardiac monitor with advanced sensing capabilities |
EP2195076A4 (en) * | 2007-09-14 | 2014-12-31 | Corventis Inc | Adherent device for cardiac rhythm management |
US20090076342A1 (en) * | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Adherent Multi-Sensor Device with Empathic Monitoring |
US8249686B2 (en) * | 2007-09-14 | 2012-08-21 | Corventis, Inc. | Adherent device for sleep disordered breathing |
WO2009036319A1 (en) * | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Adherent emergency patient monitor |
WO2009036256A1 (en) * | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Injectable physiological monitoring system |
WO2009036333A1 (en) * | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Dynamic pairing of patients to data collection gateways |
US7863862B2 (en) | 2007-10-12 | 2011-01-04 | Research In Motion Limited | Handheld electronic device with holster having a notification device |
US7794384B2 (en) | 2007-12-07 | 2010-09-14 | Terumo Heart, Inc. | Dual communication interface for artificial heart system |
US20090287120A1 (en) | 2007-12-18 | 2009-11-19 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Circulatory monitoring systems and methods |
US8290574B2 (en) | 2008-03-10 | 2012-10-16 | Koninklijke Philips Electronics N.V. | ECG monitoring system with configurable alarm limits |
EP2257216B1 (en) * | 2008-03-12 | 2021-04-28 | Medtronic Monitoring, Inc. | Heart failure decompensation prediction based on cardiac rhythm |
US8412317B2 (en) * | 2008-04-18 | 2013-04-02 | Corventis, Inc. | Method and apparatus to measure bioelectric impedance of patient tissue |
US20090275848A1 (en) * | 2008-04-30 | 2009-11-05 | Transoma Medical, Inc. | Cardiac Risk Assessment |
US20090292194A1 (en) * | 2008-05-23 | 2009-11-26 | Corventis, Inc. | Chiropractic Care Management Systems and Methods |
US9405847B2 (en) | 2008-06-06 | 2016-08-02 | Apple Inc. | Contextual grouping of a page |
US8125331B2 (en) | 2008-08-27 | 2012-02-28 | The Invention Science Fund I, Llc | Health-related signaling via wearable items |
US8130095B2 (en) | 2008-08-27 | 2012-03-06 | The Invention Science Fund I, Llc | Health-related signaling via wearable items |
WO2010025144A1 (en) * | 2008-08-29 | 2010-03-04 | Corventis, Inc. | Method and apparatus for acute cardiac monitoring |
US8734422B2 (en) | 2008-08-31 | 2014-05-27 | Abbott Diabetes Care Inc. | Closed loop control with improved alarm functions |
US8497690B2 (en) | 2008-10-27 | 2013-07-30 | Microchip Technology Incorporated | Automated capacitive touch scan |
US8126418B2 (en) | 2008-10-30 | 2012-02-28 | Medtronic, Inc. | Preselector interference rejection and dynamic range extension |
JP5115450B2 (en) | 2008-11-04 | 2013-01-09 | 沖電気工業株式会社 | Optical code division multiplexing signal generator |
US8708923B2 (en) | 2009-02-04 | 2014-04-29 | Massachusetts Institute Of Technology | Wearable system for monitoring physiological signals |
US20100234716A1 (en) * | 2009-03-12 | 2010-09-16 | Corventis, Inc. | Method and Apparatus for Monitoring Fluid Content within Body Tissues |
US8615295B2 (en) | 2009-03-17 | 2013-12-24 | Cardiothrive, Inc. | External defibrillator |
US20120165684A1 (en) | 2009-05-13 | 2012-06-28 | Monitoring Information Technologies, Inc. | Systems and Methods for Heart and Activity Monitoring |
US20100295674A1 (en) | 2009-05-21 | 2010-11-25 | Silverplus, Inc. | Integrated health management console |
US8269634B2 (en) | 2009-08-27 | 2012-09-18 | Angel Medical Systems, Inc. | Systems and methods of alarm validation and backup in implanted medical devices |
JP5909037B2 (en) | 2009-10-07 | 2016-04-26 | 日本光電工業株式会社 | Biological information monitor device with alarm priority changing function and alarm control method |
EP2491638A4 (en) | 2009-10-21 | 2014-04-23 | Micro Power Electronics Inc | Patches for battery-interfacing devices and associated systems and methods |
US20110098765A1 (en) | 2009-10-27 | 2011-04-28 | Medtronic, Inc. | Detecting lead related condition during delivery of therapeutic electrical signals |
CN105054924A (en) | 2010-05-18 | 2015-11-18 | 佐尔医药公司 | Wearable ambulatory medical device with multiple sensing electrodes |
PL2571572T3 (en) * | 2010-05-18 | 2017-05-31 | Zoll Medical Corporation | Wearable therapeutic device |
US8904214B2 (en) | 2010-07-09 | 2014-12-02 | Zoll Medical Corporation | System and method for conserving power in a medical device |
US8428703B2 (en) | 2010-08-25 | 2013-04-23 | Angel Medical Systems, Inc. | Acute ischemia detection based on parameter value range analysis |
US8428704B2 (en) | 2010-08-25 | 2013-04-23 | Angel Medical Systems, Inc. | Threshold adjustment schemes for acute ischemia detection |
US9937355B2 (en) | 2010-11-08 | 2018-04-10 | Zoll Medical Corporation | Remote medical device alarm |
WO2012078857A2 (en) | 2010-12-09 | 2012-06-14 | Zoll Medical Corporation | Electrode with redundant impedance reduction |
BR112013014219A2 (en) | 2010-12-10 | 2016-09-13 | Zoll Medical Corp | therapeutic device |
US9427564B2 (en) | 2010-12-16 | 2016-08-30 | Zoll Medical Corporation | Water resistant wearable medical device |
EP3610919A1 (en) | 2012-03-02 | 2020-02-19 | Zoll Medical Corporation | A system comprising a wearable therapeutic device |
EP3932478A1 (en) * | 2013-06-28 | 2022-01-05 | Zoll Medical Corporation | Ambulatory medical device capable of delivering therapy to a patient |
-
2008
- 2008-04-30 US US12/150,720 patent/US8271082B2/en active Active
- 2008-05-29 DE DE102008025709.5A patent/DE102008025709B4/en active Active
- 2008-06-06 JP JP2008148804A patent/JP5492388B2/en active Active
- 2008-06-06 FR FR0853744A patent/FR2916982B1/en active Active
-
2012
- 2012-09-12 US US13/612,400 patent/US9370666B2/en active Active
-
2014
- 2014-01-29 JP JP2014014694A patent/JP5824540B2/en not_active Expired - Fee Related
-
2015
- 2015-10-06 US US14/876,322 patent/US10328275B2/en active Active
- 2015-10-09 JP JP2015201267A patent/JP6142442B2/en active Active
-
2016
- 2016-07-08 US US15/205,542 patent/US10434321B2/en active Active
-
2019
- 2019-08-21 US US16/546,655 patent/US11207539B2/en active Active
-
2021
- 2021-11-17 US US17/455,235 patent/US20220072323A1/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030004547A1 (en) * | 1997-03-07 | 2003-01-02 | Owen James M. | Defibrillation system |
US20060116724A1 (en) * | 2002-12-13 | 2006-06-01 | David Snyder | External defibrillator with shock activated by cessation of precordial compressions |
US20180153765A1 (en) * | 2011-04-08 | 2018-06-07 | Zoll Medical Corporation | System for Assisting Rescuers in Performing Cardio-Pulmonary Resuscitation (CPR) on a Patient |
Also Published As
Publication number | Publication date |
---|---|
JP5824540B2 (en) | 2015-11-25 |
DE102008025709B4 (en) | 2019-04-25 |
US20160023014A1 (en) | 2016-01-28 |
US20080306562A1 (en) | 2008-12-11 |
JP2008302228A (en) | 2008-12-18 |
US20160317826A1 (en) | 2016-11-03 |
US10434321B2 (en) | 2019-10-08 |
FR2916982B1 (en) | 2013-10-11 |
FR2916982A1 (en) | 2008-12-12 |
US20130013014A1 (en) | 2013-01-10 |
JP2016005814A (en) | 2016-01-14 |
DE102008025709A1 (en) | 2009-05-14 |
JP6142442B2 (en) | 2017-06-07 |
US8271082B2 (en) | 2012-09-18 |
JP5492388B2 (en) | 2014-05-14 |
US20190374785A1 (en) | 2019-12-12 |
US11207539B2 (en) | 2021-12-28 |
JP2014111162A (en) | 2014-06-19 |
US10328275B2 (en) | 2019-06-25 |
US9370666B2 (en) | 2016-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220072323A1 (en) | Medical device configured to test for user responsiveness | |
US11877854B2 (en) | Wearable medical treatment device with motion/position detection | |
US10478631B2 (en) | Wearable cardioverter defibrillator (WCD) system using sensor modules with reassurance code for confirmation before shock | |
US7986998B2 (en) | Methods and devices for detection of context when addressing a medical condition of a patient | |
US6609023B1 (en) | System for the detection of cardiac events | |
US5190034A (en) | Implantable arrhythmia system with protection against release of unneeded pulses | |
US6208251B1 (en) | System for monitoring and assisting isolated persons, and device for implementing the system | |
EP1436045A2 (en) | Suspension of implantable device | |
AU4871999A (en) | Person monitoring apparatus | |
NL1031117C1 (en) | System and method for monitoring a heartbeat, as well as a sensor and a processing unit as part of this system. | |
EP0305080A2 (en) | Portable apparatus for continuously monitoring peripheral blood flow |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ZOLL MEDICAL CORPORATION, MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DONNELLY, EDWARD J.;CLARK, JOHN G.;SZYMKIEWICZ, STEVEN J.;AND OTHERS;REEL/FRAME:058135/0660 Effective date: 20080428 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |